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DETERMINATION OF THE SYNERGISTIC ACUTE EFFECTS OF 
ANTIBIOTICS ON METHANOGENIC PATHWAY 
SUMMARY 
Antibiotics are defined the chemotherapeutic agents that inhibit or abolish the growth 
mechanisms of microorganisms. Large quantities of antibiotics are used in human 
and veterinary medicine. Approximately 500 ton of antibiotics are produced and 
consumed every year. After consumption, antibiotics and/or their metabolites are 
excreted into the effluent and reach the sewage treatment plants, and, if they are not 
degraded, will eventually enter the environment. Antibiotics have been detected in 
the ng/L and µg/L range in municipal sewage, effluents of treatment plants, surface 
water and groundwater. On the other hand, emissions from production plants have 
major importance. It has been found that, the concentration of antibiotics in 
pharmaceutical wastewater is in mg/L level. The presence of antibiotic in 
wastewaters may negatively effect biological processes in treatment plants either by 
influencing the composition of the microbial community or direct inhibition of 
pollutant degradation. Furthermore, antibiotics do not occur as pure substances in 
environment. They are present as multi-component mixtures. Mixtures generally 
cause higher effects than each of their comprising substances alone.  
In this thesis, the mixture short-term effects of selected antibiotics on methanogenic 
activity of a microbial community under anaerobic conditions were determined. In 
this scope, acute tests were designed based on a three-way factorial design where one 
factor was the composition of the substrate solution (acetate, butyrate, and VFA 
mixture), another factor was the composition of antibiotic mixtures 
(Sulfamethoxazole, Erythromycin, and Tetracycline) and the last factor was 
concentration of antibiotics added (1 – 250 mg/L). Substrate removal was monitored 
by VFAs measurements, together with daily measurements of biogas and methane 
generation. In addition, the microbial community structure of seed sludge which used 
in acute tests were identified for determining the microorganisms which associated 
with degradation of selected substrates.  
Statistical analyses showed that, there is a strong correlation between antibiotic 
mixture concentration and methane generation. For all substrate conditions, 250 
mg/L ST mixture had the highest inhibitory effect on total methane production. After 
100 mg/L, short-term inhibitory effect of antibiotic mixtures was seen clearly in all 
test bottles. The results showed that, mixtures had higher inhibition effect on total 
methane production of acetoclastic methanogens than single compounds. 
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 ANTİBİYOTİKLERİN METANOJENİK YOLİZLERİ ÜZERİNDE ÇOKLU 
AKUT ETKİLERİNİN BELİRLENMESİ 
ÖZET 
Antibiyotikler mikroorganizmaların büyüme mekanizmalarını inhibe eden ya da 
durduran kemoterapötik ajanlar olarak tanımlanır. Tıp ve veterinerlik alanlarında 
büyük miktarda antibiyotik kullanılmaktadır. Her yıl yaklaşık olarak 500 ton 
antibiyotik üretilmekte ve tüketilmektedir. Tüketim sonucunda, antibiyotikler ya da 
onların metabolitleri atıksuya karışarak atıksu arıtma tesislerine ulaşmakta, burada 
parçalanmama halinde ise çevreye karışmaktadırlar. Yüzeysel sular ve atıksularda 
antibiyotik konsantrasyonları ng/L ve µg/L seviyelerinde tespit edilmişken, ilaç 
endüstrisi ve hastane atıksularında antibiyotik konsantrasyonları mg/L düzeyindedir. 
Yapılan çalışmalar antibiyotiklerin düşük konsantrasyonlarda dahi çevrede olumsuz 
etkilere sebep olabildiklerini göstermektedir. bu maddelerin su ve toprakta birikimi, 
doğada antibiyotiğe dirençli patojenlerin gelişmesine neden olmaktadır. Bu durum 
halk sağlığını tehdit etmektedir. Antibiyotik arıtımında ozonlama, fenton prosesi ile 
oksidasyon, UV ile parçalama ve fotodegredasyon gibi kimyasal teknolojiler 
kullanılmaktadır. İlaç endüstrisi atıksuları yüksek organik madde içerikleri nedeniyle 
anaerobik arıtıma uygundur. Atıksuda bulunan antibiyotikler, arıtma tesislerindeki 
biyolojik üniteler üzerinde mikrobiyal kompozisyonun değişmesine sebep olarak ya 
da direk olarak kirletici degradasyonunu inhibe ederek negatif etkide bulunabilirler. 
Antibiyotikler çevrede saf maddeler olarak değil, çok bileşenli karışımlar halinde 
bulunular. Karışım halinde genellikle tekli olarak bulunduklarından daha fazla etkiye 
sebep olurlar. Literatürde antibiyotikler ile ilgili çalışmalar genellikle tekli etkiler 
üzerine yoğunlaşmıştır, antibiyotik karışımlarının biyolojik sistemler üzerindeki 
bütünleşik etkilerini inceleyen sınırlı sayıda çalışma bulunmaktadır.  
 
Bu tezde, seçilmiş olan antibiyotik karışımlarının havasız koşullarda mikrobiyal 
komünitenin metanojenik aktivitesi üzerindeki kısa süreli inhibisyon etkisi 
incelenmiştir. Bu testlere ek olarak, akut testlerde kullanılan aşı çamurunun 
mikrobiyal komünite yapısı, antibiyotiklerin farklı yolizleri üzerindeki mikrobiyal 
komüniteye etkisinin belirlenebilmesi için tanımlanmıştır.  
 
Bu kapsamda, üç değişkenli akut testler tasarlanmıştır. Birinci değişken substrat 
çözeltisinin içeriğidir. Asetoklastik metanojenler üzerindeki etkilerin belirlenebilmesi 
için asetat, tüm metanojenler ve homoasetojenler üzerindeki etkilerin 
belirlenebilmesi için uçucu yağ asidi karışımı ve bütirat karbon kaynağı olarak 
belirlenmiştir. Diğer değişken antibiyotik karışımının kompozisyonudur. İlaç 
endüstrisi atıksularında yüksek konsantrasyonlarda bulunan, ekosisteme başta evsel 
atıksular olmak üzere birçok kaynaktan giriş yapan ve insanlarda görülen 
enfeksiyonel hastalıkların tedavisinde sıklıkla kullanılan, aynı zamanda üç farklı 
antibiyotik mekanizmasını temsil eden antibiyotiklerden Sulfametoksazol, 
Eritromisin ve Tetrasiklin seçilmiştir. Son değişken ise antibiyotik 
xxii 
 
konsantrasyonudur  (1 – 250 mg/L). Akut testlerde kullanılacak olan stok çamurunu 
hazırlamak için toplam hacmi 10 litre olan ve 8 litre aktif hacimde işletilen anaerobik 
ardışık kesikli reaktör (AAKR) kurulmuştur. Sistem iki aşamalı anaerobik-aerobik 
biyolojik arıtma sistemleri uygulanan bir alkollü içki endüstrisinin atıksularını arıtan 
yukarı akışlı anaerobik çamur yatağının 1.aşamasından alınan aşı çamuru ile inoküle 
edilmiştir. Reaktörde UAKM konsantrasyonu 12250 mg/L tutulmuş, organik 
yükleme 1250 mg/L.gün KOI'den 6250 mg/L.gün KOI'ye kademeli olarak 
çıkarılmıştır. Reaktör stabil hale geldikten sonra, öncelikle testlerde kullanılacak 
optimum substrat konsantrasyonunu belirlemek için 500 – 1000 – 1500 – 2000 mg/L 
konsantrasyonlarda substrat içeren akut testler kurulmuştur. Üç substrat için de 1500 
mg/L optimum konsantrasyon olarak belirlenmiştir. Akut testlerde 100 mL aktif 
hacimli, 120 mL’lik serum şişeleri kullanılmıştır. Şişelere son konsantrasyon 1000 
mg/L TUKM olacak şekilde AAKR’den alınan aşı çamurundan eklenmiştir. 
Testlerde kullanılan besiyeri OECD 311 protokolünde belirtilen şekilde 
hazırlanmıştır. Test süresi substrat cinsine bağlı olarak 8 ile 12 gün arasında 
değişmiştir. Test süresince serum şişeleri 35±2°C'de tutulmuş ve her gün el ile 
çalkalanmıştır. Basınç değişimi 5-7000 mbar arasında ölçüm yapabilen manometre 
ile ölçülmüştür. Aşı çamurunun mikrobiyolojik karakterizasyonu için bakteriyel ve 
arkeal klon kütüphaneleri kurulmuş, mikrobiyal çeşitlilik HRM analizi ile 
belirlenmiştir. Analiz sonucunda 12 farklı bakteriyel ve 22 farklı arkeyal tür tespit 
edilmiştir. Bu türleri temsil eden numunelere dizileme analizi yapılmıştır. Bakteriyel 
klon kütüphanesinin %21’i bütirat ve propiyonat degradasyonundan sorumlu türleri 
içeren Firmicutes filumu oluşturmaktadır. Toplam metan üretiminin yaklaşık 
%70’inden sorumlu asetoklastik metanojenleri içeren Methanosarcinales filumu ise 
arkeyal klon kütüphanesinin %27’sini oluşturmaktadır.  
 
Test şartlarında, hiçbir koşulda tam metan inhibisyonu görülmemiştir. Yapılan 
istatistiksel analizler antibiyotik karışımının konsantrasyonu ile toplam metan üretimi 
arasında anlamlı bir ilişki olduğunu göstermektedir. Kurulan test şişelerinin tümünde, 
antibiyotik konsantrasyonu arttıkça, metan üretiminde düşüş gözlenmiştir. Tüm 
setlerde en yüksek inhibisyon etkisini 250 mg/L ST içeren test şişeleri göstermiştir. 
Her üç substrat için toplam metan üretimindeki düşüş 100 mg/L’den sonra 
görülmüştür, Asetat setinde, antibiyotik karışımı içermeyen kontrol test şişelerinde 
toplam metan üretimi 64 mL olarak ölçülmüştür. Bu değer, ST içeren test şişelerinde 
1 mL’ye düşmüştür. EC50 değerleri ETS için 50 mg/L, ET 65 mg/L, ST için 102 
mg/L ve ES için 138 mg/L olarak hesaplanmıştır. Karışımların EC50 değerleri, bu 
karışımı oluşturan antibiyotiklerin herbiri için hesaplanan değerden daha düşüktür. 
Antibiyotik karışımları asetoklastik metanojenler üzerinde sinerjistik etki 
göstermektedir. Bütirat setinde, kontrol şişelerinde toplam metan üretimi ortalama 
103 mL’dir. 250 mg/L ST içeren test şişelerinde bu değer 49 mL’ye düşmüştür. 
Bütirat setinde EC50 değeri ST karışımı için 96 mg/L olarak hesaplanmış, diğer 
antibiyotik karışımlarında EC50 değerinin test edilen konsantrasyonların üzerinde 
olduğu tahmin edilmektedir. Antibiyotik karışımlarının bütirat degradasyonundan 
sorumlu bakteriler üzerindeki etkisi iki şekilde açıklanabilir. Karışımlar, mikrobiyal 
popülasyon üzerinde antagonistik etki göstermiş olabilirler, ya da bütirat 
degradasyonundan sorumlu bakteriler bu antibiyotiklere karşı dirençlidirler. Karbon 
kaynağı olarak UYA karışımını içeren deney setinde, kontrol şişelerinde toplam 
metan üretimi 80 mL, metan üretiminde en yüksek inhibisyon etkisi gösteren 250 
mg/L ST içeren test şişelerinde ise bu değer 31 mL’dir. EC50 değerleri ETS için 88 
mg/L, ET 106 mg/L, ST için 52 mg/L olarak hesaplanmış, ES karışımı için ise EC50 
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değerinin 250 mg/L’nin üzerinde olduğu düşünülmektedir. UYA setinde ETS, ET ve 
ES karışımlarının EC50 değerleri karışımı oluşturan bileşenlerin EC50 değerlerinden 
yüksek olduğu görülmüş, bu karışımlarda antagonistik etki gözlenmiştir. ST 
karışımında ise EC50 değeri, SMX’in EC50 değerinden düşüktür. UYA 
degradasyonunda ST karışımı sinerjistik etki göstermiştir. Sonuç olarak, antibiyotik 
karışımlarının farklı metanojenik yol izleri üzerindeki etkilerinin aynı olmadığı tespit 
edilmiştir. 
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1.  INTRODUCTION 
Antibiotics are defined as chemotherapeutic agents that inhibit or abolish the growth 
mechanisms of microorganisms (Kümmerer, 2009a). They are the most intensively 
used and important groups of pharmaceuticals. Large quantities of antibiotics are 
used in human and veterinary medicine. They have also been used for treating and 
preventing plant infections and growth promotion in animal farming (Martinez, 
2009). Substantial amounts of antibiotics release in natural ecosystem because of 
these applications.  
Antibiotics have been detected in the ng/L and µg/L range in municipal sewage, 
effluents of treatment plants, surface water and groundwater (Kümmerer, 2008). On 
the other hand, emissions from production plants have minor importance. It has been 
found that, the concentration of antibiotics in pharmaceutical wastewater is in mg/L 
level (Amin et al., 2006). Antibiotic consumption varies between countries. While in 
the United States, the antibiotic consumption in human medicine is 17 g per capita 
and year, in various European countries the consumption of antibiotics for medical 
purposes ranges between 4 – 8 g per capita and year (Alexy, 2006). 
Generally, antibiotics are not metabolized after their application. They are released 
into the effluent and they reach sewage treatment plants. If they are not degraded in 
the treatment plant, they can reach in the environmental compartments (Alexy et al., 
2004).The presence of antibiotic in wastewaters may negatively affect biological 
processes either by influencing the composition of the microbial community or direct 
inhibition of pollutant degradation. Besides these effects, release of antibiotics into 
the environment increases the risk of bacterial resistance development (Kümmerer, 
2009b). 
Inhibition effects of a selected chemical can be evaluated with short-term (acute) and 
long-term (chronic) tests. Acute experiments comprise a microbial community 
selection and sustainability of the selected organic substrate in the system and not 
previously exposed to the inhibitor. Short-term tests represent the effect of pulse 
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discharge of inhibitors, possibly at high concentrations to the joint treatment systems, 
while long-term tests may be useful in assessing the continuous impact of lower 
antimicrobial concentrations, similar to those found in domestic wastewater 
(Cetecioglu et al., 2012). Different opinions were expressed in the literature. 
According to Kummerer (2009a), acute tests would be inappropriate for determining 
the effects of antibiotics on bacteria, because of short incubation period. On the other 
hand, Alighardashi and his colleagues (2009) state that the microbial community 
becomes adapted to a synthetic substrate in chronic tests which is a different situation 
in a full-scale treatment plant.  
Most risk assessment is based on single compounds in the literature. Antibiotics are 
present as multi-component mixtures in environment. It has been found that mixtures 
might exhibit different effects than single compounds (Silva et al., 2002; Cleuvers, 
2004, 2008; Backhause et al., 2008; Pomati et al., 2007). Knowledge about the 
mixtures toxicity is limited in the literature. 
1.1 Aim and Scope 
Approximately 500 ton of antibiotics are produced and consumed every year. 
Manufacturing plants has the major importance on the emissions of antibiotics to the 
environment. Pharmaceutical wastewaters have antibiotic concentrations, on the 
order of a few mg/L. Generally, pharmaceutical wastewater is characterized by high 
COD concentration, and some pharmaceutical wastewaters can have COD 
concentration as high as 80,000 mg/L. Effluent from pharmaceutical wastewater is 
usually treated using ozonation, fenton oxidation, sorption etc. However, due to high 
COD content, pharmaceutical wastewaters could be treated by anaerobic biological 
systems  (Chelliapan & Sallis, 2011). 
There are many studies in literature, which evaluate inhibition effect of the individual 
antibiotics on treatment systems (Fountoulakis et al., 2004; Amin et al., 2006; 
Gartiser et al., 2007; Cetecioglu et al., 2012). As it is known that antibiotics are not 
present as single compound substances in environmental compartment. The 
information on inhibition effects of antibiotics mixtures is very limited in the 
literature.  
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The aim of this thesis is to determine the mixture short-term effects of selected 
antibiotics on methanogenic activity of a microbial community under anaerobic 
conditions.  
In this scope, acute tests were constructed to evaluate the short-term effect of 
antibiotic mixtures under three different carbon sources (acetate, butyrate, and VFA 
mixture). Three widely used antimicrobials, sulfamethoxazole, erythromycin and 
tetracycline were selected for the study. The antibiotic dosages were in the range of 
1.0–250 mg/L. Control tests, which had not contained antibiotic, were set-up for the 
reliable evaluation. Biogas generation/composition and substrate removal were 
monitored during the test period.  The seed sludge was acclimated to a synthetic 
wastewater for reliability of tests. In addition, the microbial community structure of 
the seed sludge used in acute tests identified to determine the microorganisms, which 
had role on the degradation of the selected substrates.  
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2.  THEORETICAL BACKGROUND 
2.1 Antibiotics 
Antibiotics are the compounds, which occurred naturally by microorganisms or 
produced by synthetically such as sulfa drugs or semi synthetically with modification 
of natural origin compounds (Kemper, 2008; Kümmerer, 2009a). The first antibiotics 
were natural origin, e.g. penicillin produced by fungi in the genus Penicillium, or 
streptomycin from bacteria of the genus Streptomyces (Kümmerer, 2009a).  
Antibiotics are apparently the most effective drugs in human medicine so far. In 
addition to the applications in human and animal medicine, antibiotics are used as a 
growth promoter in animal farming. They are also used for preventing and treating 
plant infections. Substantial amounts of antibiotics are released in environmental 
compartment because of these applications (Martinez, 2009).  
2.1.1 Classification of antibiotics 
There are various ways to classify antibiotics. They could classify according to their 
chemical structure or modes of action. Most antibiotics fall into seven main 
categories, based on their site activity. These groups consist of inhibition of cell wall 
synthesis, protein synthesis, DNA and RNA synthesis or competitive inhibition of 
folic acid synthesis and membrane disorganizing agents (Alanis, 2005). Table 2.1, 
shows the mechanism of actions of antibiotics.  
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Table 2.1 The mechanism of actions of antibiotics 
Mechanism of Action Antibiotic families 
Inhibition of cell wall synthesis Beta-lactams(penicillins, carbapanems); 
glaycopepdides; cyclic lipopeptides(daptomycin) 
Inhibition of protein synthesis Tetracyclines; aminoglycosides; oxazolidonones; 
streptogramins;ketolides;macrolides;lincosamides 
Inhibition of DNA synthesis Fluoroquinolones 
Inhibition of RNA synthesis Rifampin 
Competitive inhibition of folic 
acid synthesis 
Sulfonamides; trimethoprim 
Membrane disorganizing agents Polymyxins (Polyxin-B, Colistin) 
Other mechanisms Metronidazole 
 
Modes of antibiotic action are shown schematically in Figure 2.1. 
 
 
Figure 2.1 : Targets for antibiotics (John Wiley & Sons, Inc., 2004). 
Tetracycline (TET), sulfamethoxazole (SMX) and erythromycin (ERY) were chosen 
in this study because these antibiotics are the most commonly used antibiotics in 
human and veterinary medicine as well as they are represent different modes of 
action  (Chopra & Roberts, 2001; Baran, 2011).  
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2.1.1.1 Tetracycline 
The tetracyclines, which were discovered in the 1940s, are a family of antibiotics that 
inhibit protein synthesis by preventing the attachment of aminoacyl-tRNA to the 
ribosomal acceptor (A) site. Tetracyclines are broad-spectrum agents, exhibiting 
activity against a wide range of gram-positive and gram-negative bacteria, atypical 
organisms such as chlamydiae, mycoplasmas, and rickettsiae, and protozoan 
parasites (Chopra & Roberts, 2001). Tetracyclines are toxic to both bacterial and 
mammalian ribosomes, although tetracyclines reach much higher concentrations 
within bacterial cells (McDermott et al., 2003). 
Tetracyclines are characterized by a partially conjugated four-ring structure with a 
carboxyamide functional group (Figure 2.2). The molecule of tetracycline has several 
ionizable functional groups of a rather unusual type, and the charge of the molecule 
depends on the solution pH. Tetracyclines are relatively stable in acidic media, but 
not in alkaline conditions, and form salts in both media. In general, these compounds 
are sparingly soluble in water; however, solubility of the corresponding 
hydrochlorides is reported to be much greater (Sarmah, Meyer, & Boxall, 2006). 
 
Figure 2.2 :  Molecular Structure of Tetracycline 
Tetracyclines are one of the cheapest classes of antibiotics available today, making 
them attractive for use in developing countries with limited health care budgets 
(Roberts, 2003). 
The tetracyclines have applications for the treatment of infections in human and 
veterinary medicine. They are used in animal farming as growth promoters for food 
animals. Besides these applications, there are also used in aquaculte to control 
infenctions in salmon, catfish and lobster (Chopra & Roberts, 2001). 
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2.1.1.2 Sulfamethoxazole 
Sulfonamides were the first drugs with a selective effect on bacteria, and which, 
could be used systemically against bacterial infections (Sköld, 2000). 
Sulfamethoxazole is one of the sulfonamide group antibiotics, which is the inhibitor 
of nucleic acid metabolism.  
Sulfonamides are structural analogues of p-amino benzoic acid (PABA). PABA is a 
substrate in the synthesis of tetrahydrofolic acid, a donor of one-carbon units in the 
synthesis of purine and pyrimidine nucleotides. Sulfonamides competitively compete 
for the (dihydropteroate synthetase) enzyme active site, and block the formation of 
nucleotide precursors. These drugs can also be incorporated into a compound that 
resembles dihydrofolate and that in turn can inhibit another enzyme in the pathway, 
dihydrofate reductase (McDermott et al., 2003).  Figure 2.3 shows the chemical 
structure of sulfamethoxazole. 
 
Figure 2.3 :  Chemical structure of Sulfamethoxazole 
Sulfamethoxazole is among the most frequently detected sulfonamides in municipal 
sewage  (Choi et al., 2007;  Brown et al., 2006; Gobel et al., 2007; Levine et al., 
2006). However, concentrations of this drug in wastewater treatment plant influents 
and effluents vary significantly, depending on antibiotic consumption patterns and 
the types of wastewater treatment processes employed  (Le-Minh et al., 2010). 
2.1.1.3 Erythromycin 
The RNA and protein machinery of the prokaryotic ribosomes is sufficiently distinct 
from the analogous eukaryotic machinery that there are many inhibitors of protein 
synthesis, targeting different steps in ribosome action, with selective antibacterial 
action. These include such important antibiotics as the macrolides of the 
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erythromycin class (Walsh, 2000).  Figure 2.4 shows the chemical structure of 
erythromycin. 
 
 
Figure 2.4 : Chemical structure of Erythromycin 
Erythromycin is among the principal representatives of the macrolide antibiotics for 
clinical use. An important difference between erythromycin and other macrolides, 
such as clarithromycin and roxythromycin, is the sensitivity of erythromycin to pH. 
Under acidic conditions, erythromycin is unstable and is transformed into an inactive 
anhydro-form by the loss of one H2O molecule. At the ambient operational pH 
ranges (6.5-8) of most municipal wastewater treatment plants, erythromycin can exist 
in both its active original form and as the inactive erythromycin-H2O (Le-Minh et 
al., 2010). 
2.1.2 Sources of antibiotics in the environment 
The presence of pharmaceuticals in the environment generally results from human 
and veterinary medicine, as well as in aquaculture, for the purpose of preventing 
(prophylaxis) or treating microbial infections. The excretion of incompletely 
metabolized antibiotics by humans and animals is the primary source of antibiotics in 
the environment (Figure 2.5). Other sources include the disposal of unused 
antibiotics and waste from pharmaceutical manufacturing processes. Residential 
(private residences, dormitories, hotels, and residential care facilities) and 
commercial facilities (including hospitals) are known contributors of antibiotics to 
municipal wastewater. Other potential contributors of antibiotics to surface and 
ground water are effluent from wastewater treatment plants (Golet et al., 2002; 
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Hirsch et al., 1999; McQuillan et al., 2002; Alder et al., 2003) and industrial 
facilities (including pharmaceutical plants) (Guardabassi et al., 1998). 
 
Figure 2.5 : Scheme showing possible sources and pathways for the occurrence of         
                    pharmaceutical residues in the aquatic environment (Heberer, 2002). 
Wastewater treatment processes achieve variable and often incomplete removal of 
antibiotics, resulting in discharge of antibiotics into surface waters (Brown, 2006 ). 
2.1.2.1 Natural background 
The question of natural background concentrations of antibiotics is important for the 
risk assessment of antibiotics. Soil bacteria produce several antibiotics such as some 
ß-lactams, streptomycins, aminoglycosides and others. The group of Actinomycetes 
includes many soil bacteria such as Streptomycetes. Streptomycetes produce 
antibiotics. The antibiotic activity from local soil samples is variable and requires the 
examination of several samples to find a few that produce zones of inhibition 
(Kümmerer, 2009a).  
2.1.2.2 Animal livestock and aquaculture 
Although most antibiotics are used for the treatment of infections in animals, a 
significant portion of these are also used in animal feed as a supplement to promote 
growth in food animals. The use of antibiotics for animal growth promotion is not 
new; these pharmaceuticals were approved in the United States and United Kingdom 
in 1949 and 1953, respectively (Kumar et al., 2005). Some drugs are considered feed 
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additives, often improving and thereby allowing animals to be brought to market 
faster at lower cost (Boxall, 2003). Since most growth promoters have been banned 
within the EU, only four compounds remained in this group of feed additives, and 
these were banned in 2006. The World Health Organization advises abandonment of 
use of antibiotics as growth promoters, as data show that there is no need for this 
(Alexy & Kümmerer, 2006). 
During livestock production, veterinary drugs enter the environment through removal 
and subsequent disposal of waste material (including manure/slurry and “dirty” 
waters), via excretion of faeces and urine by grazing animals, through spillage during 
external application, via wash-off from farmyard hard surfaces, or by direct 
exposure/discharge into the environment (Boxall, 2010).  
For aquaculture treatments, the drug can be added directly to the aquatic 
environment. The current definition of aquaculture, according to FAO, is ‘‘the 
farming of aquatic organisms including fish, molluscs, crustaceans and aquatic 
plants”. Farming implies some sort of intervention in the rearing process to enhance 
production, such as regular stocking, feeding and protection from predators 
(Kümmerer, 2009a). After the application of antibiotics in aquaculture, the drugs can 
settle into the sediments (directly, via fish feed, or via fish excrement). In this 
particular form of application, substantial amounts of the drugs are neither 
metabolized nor degraded. Thus, oxytetracycline, a drug frequently used in 
aquaculture worldwide, has been detected at a very high concentration (285 mg/kg) 
in the sediment of a fish farm (Hamscher, 2006). 
2.1.2.3 Agriculture 
Antibiotics have been used since the 1950s to control certain bacterial diseases of 
high-value fruit, vegetable, and ornamental plants (Kümmerer, 2009a). Antibiotics 
can also excrete in the environment via land application of manure, which is the 
common practice in many countries. Because of the persistence of various veterinary 
pharmaceuticals in liquid manure, these compounds reach soil after the fertilization 
process. Recently, tetracyclines were detected on farmed land at concentrations of up 
to 300 μg/kg soil, demonstrating that, this class of antibiotics is only slowly degraded 
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under field conditions and may accumulate in soil after repeated fertilization with 
liquid manure from intensive pig farming (Hamscher, 2006). 
2.1.2.4 Human medicine/hospital 
It is widely accepted that patient use is the primary source of human medicines in the 
environment.  In the EU, consumption of antibiotics for medical purposes amounths 
to a total of 22 g per capita and year, while in the United States the available data 
give a figure of about 17 g (Alexy, 2006). Kümmerer and Henninger (2003) reported 
that, in Germany during 1999, hospitals were responsible for 26% (105 t) of the 
country’s antibiotic consumption and estimated that 86 t of antibiotic agents were 
released into the aquatic environment from hospitals.  
The emission of antibiotics from hospitals and households into municipal sewage 
results in an annual average expected concentration nearly 71 μg/L in Germany. In a 
study carried out by Ohlsen and his friends, showed that some compounds such as 
siprofloxacin (51 µg/L), erythromycin (27 µg/L) and dehydratoerythromycin (83 
µg/L) were found at concentrations > 10 µg/L. Separate collection of patients’ 
excretions is often impossible for organizational, economic, and technical reasons. In 
addition, the antibiotics, which are emitted from hospitals to the sewage treatment 
plants, represent only 30% of the total antibiotic influent to Sewage treatment plants 
(Alexy & Kümmerer, 2006). 
2.1.2.5 Wastewater treatment plant 
Sewage treatment plants play an important role in the life cycle of antibiotics in 
modern society. The main transport pathways of antibiotics into the ambient 
environment are via Sewage treatment plants, where they may be only partially 
eliminated (Xu et al., 2007). 
In general, sulfonamides (sulfamethoxazole), macrolides (roxythromycin and a 
decomposition product of erythromycin: dehydrato-erythromycin), tetracyclines, 
andfluoroquinolones (ciprofloxacin) were the most frequently analysed antibiotics in 
municipal wastewater (Alexy & Kümmerer, 2006). The concentrations of antibiotics 
in the inﬂuent/efﬂuent from the Sewage trematment plants ranged from several 
hundred ng/L to several µg/L (Xu et al., 2007).  
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Studies have shown that most antibiotics are not fully eliminated in conventional 
wastewater treatment and are then released into the environment. The overall 
removal efficiency of a Spanish sewage treatment plant was 60% for the antibiotic 
sulfamethoxazole (Alexy & Kümmerer, 2006). 
2.1.2.6 Pharmaceutical industry 
Emissions from production plants have minor importance. Production of 
pharmaceuticals involves series of steps, often involving sevaral different companies 
and production sites, in order to produce a finished pharmaceutical product. At each 
stage in the production process, as with most types of chemical production, there is a 
risk that chemical waste enters the environment (Larsson et al., 2008). 
Larsson et al. (2007) reported the occurrence of “extremely high levels of 
pharmaceuticals” in effluent from a wastewater treatment plant serving 90 bulk drug 
manufacturers in Patancheru, near Hyderabad, India. In addition to this study, Li et 
al. (2008) reporting the occurrence of high concentrations of oxytetracycline (19,500 
± 2,900 µg/L) in the treated outflow effluent from a wastewater treatment works in 
Nebei Province. 
2.1.3 Effects  
Antibiotics are designed to affect microorganisms such as bacteria and fungi. If a 
substance is not eliminated in any way, it can reach the environment with the 
potential of adversely affecting aquatic and terrestrial organisms. It might reach 
humans again via drinking water (Kümmerer, 2008).  
Once antibiotics enter the ecosystems, they can be treated as an ecological factor, 
driving the evolution of the community structure (Aminov & Mackie, 2007). 
Antibiotics are affected in two ways: on the one hand, the microbial community can 
be severely disturbed by antibiotic activities; on the other hand, these environmental 
bacteria can acquire and provide gene-encoding resistance (Kemper, 2008).  Since 
antibiotics are efficient inhibitors of bacterial growth produced by environmental 
microorganisms, it has been widely accepted that their role in nature will be to inhibit 
microbial competitors. Antibiotic resistance determinants serve to avoid the activity 
of antibiotics. Besides selecting antibiotic-resistant mutants and favouring the 
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acquisition of antibiotic resistance determinants by gene-transfer elements that can 
spread among the environmental microbiota, antibiotic pollution can enrich the 
population of intrinsically resistant microorganisms, and reduce the population of 
susceptible microbiota (Martinez, 2009). 
2.1.3.1 Effects on treatment plants 
Antibiotics have the potential to affect the microbial community in sewage systems. 
The inhibition of wastewater bacteria may seriously affect organic matter 
degradation; therefore, effects of antibacterial agents on the microbial population are 
of great interest (Kümmerer, 2008).  
Generally, pharmaceutical wastewater is characterized by high COD concentration, 
and some pharmaceutical wastewaters can have COD concentration as high as 
80,000 mg/L, due to high COD content, pharmaceutical wastewaters could be treated 
by anaerobic biological systems. There are many studies in the literature, which 
investigated the effects and treatment potential of pharmaceutical wastewater on 
anaerobic reactors (Ince et al., 2002; Oz et al., 2002; Oktem et al., 2006; Oktem et 
al., 2008). 
A few studies have reported observed inhibition of wastewater microbial activities at 
elevated antibiotics concentrations (Amin et al., 2006; Gartiser et al., 2007; Ingerslev 
& Halling-Sørensen, 2000). For sulfonamide antibiotics, concentrations of 10-400 
mg/L were reported to inhibit microbial activities in activated sludge by more than 
20% (Ingerslev & Halling-Sørensen, 2000). A study by Amin et al. (2006) showed 
that the presence of erythromycin at concentration of 1 mg/L reduced COD removal 
efficiency and biogas production in anaerobic treatment by about 5%. A study of 
antibiotic biodegradability using the ISO closed bottle test revealed that a 
metronidazole concentration of 6 mg/L could reduce anaerobic activity by 69% 
(Gartiser et al., 2007). 
A reduction in the number of bacteria together with alterations in microbial 
populations were observed in a model sewage purification system when different 
commonly applied antibiotics were added in concentrations that may occur in 
hospital waste water  (Stanislawska, 1979;  Kümmerer et al., 2000). 
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Nitrification is an important step in wastewater purification, eliminating toxic 
ammonia. Several antibiotics proved to have low toxicity in relation to nitrifying 
bacteria in acute tests. These substances showed no effects upon nitrification in 
concentrations even higher than what might be environmentally expected (Tomlinson 
et al., 1966; Gomez et al., 1996). An antimicrobial was found to require high 
concentrations in order to inhibit the nitrification process in a short term test (2–4 h), 
but a prolonged test period over 5 d showed effects one order of magnitude below the 
inhibitory concentrations of the acute test  (Tomlinson et al., 1966). In a study by 
Dokianakis et al. (2004) the effects caused by the presence of seven different 
pharmaceuticals on a culture of nitrite-oxidizing bacteria isolated from activated 
sludge were reported. 
Acetoclastic methanogenes are the most sensitive group of microorganisms 
participating in the anaerobic digestion process. Tests showed that the 
pharmaceuticals tested (among them sulfamathoxazole) caused mild inhibition of the 
methanogenes in most cases, which was in turn directly related to the tendency of the 
compounds to adsorb on the anaerobic biomass  (Fountoulakis, 2004). 
2.1.3.2 Antibiotic resistance 
The capacity of bacteria to adapt to changes in their environment and thus survive is 
call resistance. In other words, wherever there is a change in susceptibility that 
renders an agent ineffective against a certain organism, this organism is refer to as 
resistant. Some organisms have always been  resistant to a particular agent by nature 
of their physiology or biochemistry (inherent or intrinsic resistance), while others 
have acquired resistance as a result of the selective effects due to the application of 
antibiotics by humans (acquired resistance)  (Kümmerer, 2009b). 
It was suggested that antibiotic resistance gene could be considered as environmental 
pollutants, since they are widely distributed in various environmental compartments, 
including wastewater and STPs, surface water, lagoon water of animal production 
areas, aquaculture water, sediments and soil, groundwater, and drinking water  (Rysz 
& Alvarez, 2004). The rapidly growing number of antibiotic-resistant bacterial 
pathogens severely undermines the ability to control infectious diseases and currently 
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it is one of the most challenging problems in public health care (Aminov & Mackie, 
2007). 
Antibiotic resistance genes (ARGs) are well-known ‘easy-to-get, hard-to-lose’ 
pollutants. Usually, antibiotic resistance bacteria and genes emerge in the 
environments under the selection pressure of some antibiotics, but the ARGs could 
not be easily removed from the polluted areas, even when the pressure has 
disappeared (Aminov & Mackie, 2007). This could be an explanation, why antibiotic 
resistance genes were often detected in antibiotic-free environments (Rahman et al, 
2008). 
2.1.4 Fate and removal 
Organic compounds may be eliminated by biodegradation, by non-biotic degradation 
processes such as hydrolysis and photolysis, or by sorption onto suspended particles, 
sediments and sludge in the aquatic environment (Alexy & Kümmerer, 2006 ).  
2.1.4.1 Sorption 
Binding to particles or the formation of complexes with metal cations may cause a 
loss in detectability, as well as a loss in antibacterial activity. Christian and his 
collegues (2003) demonstrated the loss of antibacterial activity for an aquaculture 
antimicrobial in seawater driven by the formation of complexes with the magnesium 
and calcium ions naturally present in marine water. 
In general, the sorption behavior of an organic compound strongly depends upon its 
chemical structure. Most antibiotics are complex chemical molecules, which may 
contain acidic and basic groups within the same molecule. Therefore, the distribution 
of such antibiotics between water and particulate matter (log KD) depends on pH 
(Alexy & Kümmerer, 2006). 
Humic substances may alter the surface properties and sites available for sorption 
and reactions. They can either suppress or promote sorption of organic compounds to 
mineral surfaces (Kümmerer, 2009a). Antibiotics can also diffuse into biofilms, 
present in sewage pipes, sludge flocks, or on stones in rivers and lakes. This may 
result in a biased risk estimate, as concentration in such “reservoirs” may be much 
higher than in the free water phase. It is not known how strongly the antibiotics are 
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sorbed onto sludge, particulate matter, bio-solids such as sewage sludge, and 
sediments, and under what circumstances they are (bio) available and active after 
sorption (Alexy & Kümmerer, 2006). 
2.1.4.2 Photolysis  
Lunestad (1995) reported that, if a substance is sensitive to light, 
photodecomposition might be crucial sicnificance in the elimination process. Some 
antibiotics such as quinolones, tetracyclines, metronidazole, and sulfonamides are 
sensitive to light. Fluoroquinolones are insensitive to hydrolysis and increased 
temperatures, but are degraded by UV light (Alexy & Kümmerer, 2006). However, 
not all compounds are photodegradable. The significance and extent of direct and 
indirect photolysis of antibiotics in the aquatic environment are different for each 
compound (Kümmerer, 2009a).  
Photochemical decomposition can play an important role in surface water as an 
additional elimination pathway or for effluent treatment. The effectiveness of the 
process depends on light intensity and frequency. Photodecomposition may not occur 
when the compounds are present in turbid water, if the surface of the water is 
shadowed by trees, or if the compounds are in soil, sewage and sewage pipes since 
they have low light exposure. Frequency relates to the absorption spectrum of a 
compound, and the absorption spectrum may be affected by sorption and 
complexation (Kümmerer, 2009a). 
Samuelsen (1989) studied the persistence of oxytetracycline and its sensitivity 
against the light, both in seawater and on the surface of sediments. The results 
showed that the compound was unstable in seawater but stable in sediments.   
2.1.4.3 Hydrolysis 
Hydrolysis is another major elimination type of organic substances in the 
environment. In general, the hydrolysis rates for oxytetracycline increase as the pH 
deviates from pH 7 and as temperature increases. The half-lives of oxytetracycline 
under investigation varied due to differences in temperature, light intensity and flow 
rate from one test tank to another. However sulphonamides and quinolones are 
resistant to hydrolysis  (Kümmerer, 2009a). 
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2.1.4.4  Biodegradation 
Biologically mediated processes (i.e. biotransformation) can result in the partial 
transformation or total mineralization of chemicals in the aquatic environment. 
Microorganisms may utilize organic compounds to gain energy. Sometimes total 
degradation does not take place and the process stopped before mineralization has 
completed. These biodegradation intermediates, i.e. the products of 
biotransformation, can be even more stable than the parent compounds. Bacteria and 
fungi are the two major groups of organisms degrading organic compounds. 
Therefore, in sewage treatment plants, surface water, groundwater, and seawater 
bacteria are assumed to be responsible for most biodegradation processes (Alexy & 
Kümmerer, 2006). 
Most antibiotics tested to date have not been biodegradable under aerobic conditions. 
No evidence of biodegradation for tetracycline was observed during a 
biodegradability test (sequence batch reactor), and sorption was found to be the 
principal removal (Kim, 2005). Some antibiotics occurring in soil and sediment 
proved to be quite persistent in laboratory testing as well as in field studies. Some do 
not biodegrade well under anaerobic conditions (Gartiser et al., 2007) others did 
(Maki et al., 2006). 
It could be assumed that microbial degradation of trace pollutants will be slower in 
surface water than in the sewage system because of its lower bacterial density and 
lower bacterial diversity. In a study examined the biodegradability of 18 clinically 
important antibiotics by Alexy and his friends (2004), showed that none of these 
antibiotics was readily biodegradable. 
2.1.4.5 Technical oxidation processes 
Antibiotic formulation effluents are well known for the difficulty of their elimination 
by traditional bio-treatment methods and their important contribution to 
environmental pollution is due to their fluctuating and recalcitrant nature. For 
advanced effluent treatment, oxidation processes are usually applied. However, 
ozonation will not work well for all types of molecules. The presence of carbon–
carbon double bonds, aromatic bonds or nitrogen is a prerequisite. 
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Li et al. (2008) investigated the effect of ozonation on the degradation of 
oxytetracycline in aqueous solution at different pH values (3, 7 and 11). The results 
demonstrate that ozonation, as a partial step in a combined treatment concept is a 
potential technique for biodegradability enhancement for effluents from 
pharmaceutical industries containing high concentrations of oxytetracycline. 
Sulfamethoxazole was efficiently degraded by ozonation (Dantas et al., 2007). 
2.2 Inhibition and Toxicity 
Inhibitors are compounds, which interact with an enzyme to slow down its rate of 
reaction.  They may occur naturally in cells, where they might be used for controlling 
metabolic reaction rates, or artificially, where they might be used as experimental 
tools in the study of enzyme reactions.  
Inhibition can take place in irreversable or reverseble types.  Reversible inhibitors 
bind to the enzyme using weak bonds, similar to those used in binding the substrate. 
These bonds form rapidly, but also break easily. Irreversible inhibitors are also 
known as enzyme inactivators. They combine with the enzyme by forming a strong, 
usually covalent bond. 
Competitive inhibition is one of the reversible types of inhibition. The simplest 
explanation for the competitive inhibition is that inhibitor binds to the same site on 
the enzyme as the substrate, forming an abortive, nonproductive complex; inhibitor 
and substrate are mutually exclusive  (Leskovac, 2003). In other words, the substrate 
and inhibitor compete for the same site, so that only one enzyme– inhibitor complex 
is possible. 
A noncompetitive inhibitor binds to an inhibitor site on the enzyme, which is remote 
from the active site and brings about a conformational change in the active site. A 
classical noncompetitive inhibitor has absolutely no effect on substrate binding. In 
fact, a change to the shape of the active site is almost certain to alter the ability of the 
substrate to bind. In this situation, inhibitors are often called mixed inhibitors, as they 
appear to have some of the properties of competitive and noncompetitive types. 
Uncompetitive inhibitors are incapable of binding to free enzyme.  They can only 
bind to the enzyme-substrate complex. This could be because the substrate is itself 
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directly involved in binding the inhibitor or because it brings about a conformational 
change in the inhibitors binding site, which was previously incapable of binding the 
inhibitor. Once the inhibitor has bound, it prevents the enzyme from turning the 
substrate into product. 
Normally an increase in substrate concentration increases the velocity of the enzyme 
reaction. Some enzymes, however, display the phenomenon of excess substrate 
inhibition. This means that large amounts of substrate can have the opposite effect 
and actually slow the reaction down. Substrate inhibition happens with this enzyme 
when two substrate molecules bind to the active site at the same time. As long as 
both substrate molecules are attached to, the active site of the enzyme is effectively 
inactive, and therefore inhibited. For this process to occur the second substrate must 
approach the active site very rapidly after the first, otherwise the first substrate would 
quickly attain the correct catalytic placement. 
Inhibitory action of a selected chemical may be experimentally evaluated in two 
different approaches: Short-term (acute) and long-term (chronic) tests: Acute 
experiments involve a microbial community selected and sustained by the selected 
organic substrate in the system and not previously exposed to the inhibitor. There are 
many different opinions about advantages and disadvantages of these approaches, 
despite that the two inhibition tests complement one another and reflect real-life 
inhibition schemes encountered in wastewater treatment: Short-term tests represent 
the effect of pulse discharge of inhibitors, possibly at high concentrations to the joint 
treatment systems, while long-term tests may be useful in assessing the continuous 
impact of lower antimicrobial concentrations, similar to those found in domestic 
wastewater (Cetecioglu et al., 2012). 
2.2.1 Mixture toxicity 
Pharmaceuticals do not occur as isolated, pure substances in an environmental 
compartment. As a broad range of different substances is used simultaneously in 
human and veterinary medicine in any given area, pharmaceuticals are present as 
multi-component mixtures in the environment. Two characteristics also make their 
joint toxic effects a major issue for hazar and risk assesment. Firstly, the ecotoxicity 
of a mixture is always higher than the effects of its individual components. Secondly, 
a mixture can have a considerable ecotoxicity, even if all components are present 
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only in low concentrations that do not provoke significant toxic effects if acting 
signly on the exposed organisms (Backhause, 2008).  
Backhouse (1999, 2000) reported that the resulting mixture effect is even higher than 
50% in the case of the ten-component mixture of quinolone antibiotics and higher 
than 15% in the case of the fourteen compound mixture (twelve pharmaceuticals plus 
two additional toxicants).   
Even mixtures of only comperatively few compounds often show a similar pattern. A 
mixture of fluoxetine and cloribric acid killed more than 50% of a water – flea 
(Daphnia) population after an exposure of six days, although a components were 
present at concentrations that did not provoke significant  effects individually  
(Flaherty & Dodson, 2005). In the same study, a significant shift in the sex ratio was 
observed after an exposure to a three-component mixture of erythromycin, triclosan 
and trimethoprim again at a mixture concentration at which all components were 
present at concentrations that did not provoke significant individual effects. 
In another study, Wilson and coworkers (2004) documented the impact of a mixture 
of four tetracyclines on plankton structure and function.  Effects on algal 
communities were observed only in concentrations greater than 200 nmol/L, which is 
actually well above environmentally realistic concentrations. Zooplankton was not 
affected significantly at the tested concentrarions. However, it should be pointed out 
that, the effects on the bacterial populations in the microcosms were not recorded, 
although these organisms are vastly more sensitive to tetracycline than algea.  
2.3 Anaerobic Degradation Pathway 
The term anaerobic process refers to a divers array of biological wastewater 
treatment systems from which dissolved oxygen and nitrate-N are excluded. In most 
instances, they are operated to convert biodegradable organic matter, both soluble 
and particulate, to methane and carbon dioxide (Grady et al., 2011).  
The transformation of complex macromolecules into biogas requires the mediation of 
severak groups of microorganisms (Haandel & Lettinga, 1994). These grpups work 
in sequence, with the products of one group serving as substrates of another group. 
Therefore, each group is lenked to other groups in chainlike fashion, with the 
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weakest links being acetate production and methane production (Gerardi, 2003). 
Four different phases can be distinguished in the overall conversion proses. The 
biochemical reactions within these stages are presented in Figure 2.6. 
 
Figure 2.6 : Anaerobic degradation pathway (Gujer & Zehnder, 1983). 
2.3.1 Hydrolysis  
Hydrolysis is the first step of the anaerobic degradation. In this prosess, complex 
particulate matter is converted into dissolved compounds with a lower molecular 
weight  (Haandel & Lettinga, 1994). Particular organic wastes consist of 
carbohydrates, proteins, and lipids which are polymers. Polymeric substances are 
large molecules consisting of many small molecules joined together by unique 
chemical bonds. The small molecules are soluble and quickly go into solution once 
the chemical bonds are broken. Hydrolytic bacteria or facultatvie anaerobes that are 
capable of performing hydrolysis achieve breakage of these unique bonds  (Gerardi, 
2003).  Hydrolysis of organic polymers is usually carried out by extracellular 
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enzymes (hydrolases) and it may or may not be the rate-limiting step of their 
bioconversion under anaerobic conditions  (Ahring, 2003). 
2.3.2 Acidogenesis 
 Dissolved compounds, generated in the hydrolysis step, are taken up in the cells of 
fermentative bacteria and after acidogenesis are excreted as simple organic 
compounds such as volatile fatty acidsi alcohols, lactic acid and mineral compounds 
such as carbon dioxide, hydrogen, ammonia and hydrogen sulphide gas. It is mainly 
the obligatory anaerobic bacteria that carry out fermentative conversion of substrate 
to product (Haandel & Lettinga, 1994). 
2.3.3 Acetogenesis 
The products of acidogenesis are converted into the final products for methane 
production: acetate, hydrogen and carbondioxide. A fraction of approximately 70 per 
cent of the COD originally present in the influent is converted into acetic acid and 
remainder of the electron capacity concentrated in the formed hydrogen (Haandel & 
Lettinga, 1994).  
In general, two different types of acetogenic mechanisms can be distinguished: (a) 
acetogenic hydrogenations and (b) acetogenic dehydrogenations. Acetogenic 
hydrogenations include the production of acetate as a sole end product either from 
fermentation of hexoses or from CO2 and H2O. Usually the step of acetogenesis in 
the anaerobic digestion refers to acetogenic dehydrogenations and specifically to the 
anaerobic oxidation of long and short (volatile) fatty acids (Ahring, 2003).   
2.3.4 Methanogenesis 
Methanogenesis is often the rate limiting step in the overall digestion process, 
although at lower temperatures this may be hydrolysis. Methane is produced from 
acetate or from the carbondioxde and hydrogen gas by acetoclastic methanogens and 
hydrogenotrophic methanoges.  
Acetoclastic methanogens: 
CH3COOH → CH4 + CO2                  (2.1) 
Hydrogenotrophic methanogens: 
4H2 + CO2 → CH4 + 2H2O                  (2.2) 
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The bacteria producing methane from hydrogen and carbon dioxide grow faster than 
those utilizing acetate, so that the acetoclastic methanogens are usually rate limiting 
with respecct to the trasnformation of complex macromolecules to biogas.  
Two important points must be emphasised with the respect to the differet prcesses 
that occur during anaerobic digestion: 
1) The removal of organic matter – COD during the acid fermentation is limited to 
the release of hydrogen. Only 30 per cent of the organic matter is converted into 
methane via the hydrogenotrophic pathway. Thus, a necessary condition for efficient 
organic matter removal in an anaerobic treatment system is that sufficient amounts of 
acetoclastic methanogens develop.  
2) Acid fermentation tends to cause a decrease in the pH because of the production of 
volatile fatty acids and other intermediates that dissociate and produce protons. As 
methanogenesis only develop well at neutral pH values, instability may arise if, the 
acid removal rate by methane production falls behind the acid production rate: the 
net production of acid will tend to decrease the pH, and thus may reduce the 
methanogenic activity further. In practice, this situation called souring of anaerobic 
reactor contents is the most common cause of operational failure of anaerobic 
systems. The danger of souring can be avoided by maintaining the proper balance 
between acidic and methanogenic digestion capacity and buffer capacity of the 
system should be sufficiently high (Haandel & Lettinga, 1994). 
2.3.5 Microbiology of anaerobic degradation 
The anaerobic degradation of complex organic matter is carried out by various 
groups of bacteria where a coordinated interaction exists  (Khanal, 2008). 
2.3.5.1 Fermentative bacteria 
Fermentative bacteria are responsible of hydrolysis and acidogenesis steps of 
anaerobic degradation. In these steps, the anaerobic species belonging to the family 
of Streptococcaceae and Entrobacteriaceae and the genera of Bacteroides, 
Clostridium, Butyrivibrio, Eubacterium, Bifidobacterium and Lactobacillus are 
involved generally (Novaes, 1986). 
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The end products are differed by the types of substrate and environmental conditions. 
Only at low hydrogen partial pressure, the formation of acetate, CO2, and H2, which 
are the major substrates for methanogens, is thermodynamically favorable. If the 
partial pressure of H2 is high, formation of propionate and some other organic acids 
occurs (Novaes, 1986). 
2.3.5.2 Hydrogen-producing acetogens 
Hydrogen-producing acetogens metabolizes C3 or higher organic acids (propionate, 
butyrate, etc.), and ethanol into acetate, H2, and CO2. The anaerobic oxidation of 
these compounds is not favorable thermodynamically by hydrogen-producing 
bacteria in pure culture. On the other hand, there is a symbiotic relationship between 
hydrogen-producing acetogens and hydrogen-consuming methanogens in coculture. 
The hydrogen-consuming methanogens use the hydrogen rapidly and keep the level 
of hydrogen partial pressure extremely low. This provides a thermodynamically 
favorable condition for the hydrogen-producing acetogens to break down the organic 
compounds into acetate, H2, and CO2 (Khanal, 2008).  
The propionic acid oxidation to acetate becomes thermodynamically favorable only 
at hydrogen partial pressure below 10
-4
 atm and for butyrate and ethanol oxidation 
below 10
-3
 and 1 atm, respectively (Pohland, 1992). 
2.3.5.3 Homoacetogens 
The end product of homoacetogenesis is acetate, which is an important precursor to 
methane generation. Homoacetogens can be either autotrops or heterotophs. While 
heterotrophic homoacetogens use organic substrates such as formate and methanol as 
a carbon source, autotrophic homoacetogens utilize a mixture of hydrogen and 
carbon dioxide (Khanal, 2008).  
CO2 + H2 → CH3COOH + 2H2O                 (2.3) 
4CO + 2H2O → CH3COOH + 2CO2                 (2.4) 
4HCOOH → CH3COOH + 2CO2 + 2H2O                (2.5) 
4CH3OH + 2CO2 → 3CH3COOH + 2CO2                       (2.6) 
 
Clostridium aceticum and Acetobacterium woodii are the two mesophilic 
homoacetogenic bacteria isolated from sewage sludge (Novaes, 1986). 
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2.3.5.4 Methanogens 
Methanogens, which were previously classified as bacteria, are now classified as 
archaea. Archaea are unique group of microorganisms that are distinguished from 
true bacteria by presence of membrane lipids, absence of basic cellular 
characteristics (e.g., peptidoglycan), and distinctive ribosomal RNA (Boone et al., 
1993). Classiﬁcation of methanogens is outlined in Table 2.2. 
Table 2.2: Classification of methanogenic bacteria (Whitman et al., 2001; Garrity et 
al., 2004) 
Class I. Methanobacteria (known to grow on H2/CO2 and formate as C source) 
   Order I. Methanobacteriales 
   Family I. Methanobacteriaceae 
     Genus I. Methanobacterium 
     Genus II. Methanobrevibacter 
     Genus III. Methanosphaera 
     Genus IV. Methanothermobacter 
   Family II. Methanothermaceae 
   Genus I. Methanothermus 
Class II. Methanococci (known to grow on H2/CO2 and formate as C source) 
   Order I. Methanococcales 
   Family I. Methanococcaceae 
      Genus I. Methanococcus 
      Genus II. Methanothermococcus 
   Family II. Methanocaldococcaceae 
      Genus I. Methanocaldococcus 
      Genus II. Methanotorris 
Class III. Methanomicrobia (known to grow on H2/CO2 and formate as C source) 
   Order I. Methanomicrobiales 
   Family I. Methanomicrobiaceae 
      Genus I. Methanomicrobium 
      Genus II. Methanoculleus 
      Genus III. Methanofollis 
      Genus IV. Methanogenium 
      Genus V. Methanolacinia 
      Genus VI. Methanoplanus 
   Family II. Methanocorpusculaceae 
      Genus I. Methanocorpusculum 
   Family III. Methanospirillaceae (known to be hydrogenotrophic) 
      Genus I. Methanospirillum 
   Order II. Methanosarcinales (known to be acetato- and methylotrophic) 
   Family I. Methansarcinaceae 
      Genus I. Methanosarcina 
      Genus II. Methanococcoides 
      Genus III. Methanohalobium 
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Table 2.2 (continued): Classification of methanogenic bacteria (Whitman et al., 
2001; Garrity et al., 2004). 
      Genus IV. Methanohalophilus 
      Genus V. Methanolobus 
      Genus VI. Methanomethylovorans 
      Genus VII. Methanimicrococcus 
      Genus VIII. Methanosalsum 
   Family II. Methanosaetaceae 
      Genus I. Methanosaeta 
Methanogenesis occur through three major pathways: CO2-reducing or 
hydrogenotrophic methanogenesis, acetotrophic or acetoclastic methanogenesis, and 
methylotrophic pathways (Boone et al., 1993).  
Hydrogenotrophic pathway contributes up to 28% of the methane generation in 
anaerobic systems. The acetoclastic pathway is a major catabolic process 
contributing up to 72% of the total methane generation  (Gujer & Zehnder, 1983).  
In acetoclastic pathway acetate is converted into methane. Methanosarcina and 
Methanosaeta (previously known as Methanothrix) are the two major genera of 
acetoclastic methanogens. Methanosarcina uses several methanogenic substrates 
such as methanol, methylamines, and sometimes H2/CO2. Methanosaeta can only 
grow on acetate. While Methanosarcina has a typical doubling time of 1–2 days on 
acetate, Methanosaeta has a doubling time of 4–9 days (Khanal, 2008).  
2.4 Molecular Methods Used for Establishing the Interactions and Functions of 
Microorganisms in Anaerobic Bioreactors 
Anaerobic digestion has been applied in wastewater treatment with success over the 
last 20 years  (Talbot, 2008). Molecular techniques have recently been applied to the 
analysis of communities in anaerobic digesters (Godon,1997;  Sekiguchi, 1998). As 
research in molecular microbiology progresses in this area, the scientific community 
has now pointed out that microorganisms found in anaerobic environments, including 
bioreactors, are extremely diverse and that their interactions and metabolic functions 
and regulation remain to be elucidated in detail. Biomonitoring digesters with high 
throughput molecular tools would be useful to predict eventual stability problems  
(Talbot, 2008). Molecular techniques can provide detailed information about the 
structure, function, dynamics, and diversity of microbial communities. Molecular 
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analysis can chracterize genes, proteins (enzymes), and metabolic products 
associated with bioenergy production at extremely low concentrations without any 
difficulties of culturability. Molecular techniques of microbial cells and communities 
can, therefore, furnish useful information about structure (who they are), function 
(what they do), and dynamics (how they change through space and time) 
(Dhamwichukorn, 2008). Figure 6 illustrates how different molecular techniques can 
be used to analyze microbial community structure, function, and metabolic 
transformation seperately or together.  
 
Figure 2.7 : Molecular techniques for analysis of microbial community structure, 
      function, and metabolic transformation  (Dhamwichukorn, 2008). 
According to Zuckerkandl and Pauling (1965), evolutionary history could be 
documented by nucleic acid sequences. The techniques are based on the RNA of the 
small ribosomal subunit (16S rRNA for prokaryotes) or their corresponding genes, 
considering it as a “molecular clock” or “evolutionary chronometer”. This molecule 
was chosen because of its universality and abundance in all living beings (103-105 
ribosomes/cell) (Sanz & Köchling, 2007). 
The prokaryotic small subunit (SSU) rRNA gene (16S rRNA) gene is highly 
conserved but it contains variable regions (Woese, 1990). The highly conservative 
regions facilite PCR amplification using only once universal primer set to amplify 
the 16S rRNA gene sequences for all eubacteria from environmental samples. The 
variable regions are different for each bacterial species, allowing accurate bacterial 
detection and identification. From these characteristics, the 16S rRNA genes help to 
determine the genetic diversity of a microbial community as well as to assist in 
identifying the phylogenetic affiliation of its members (Dhamwichukorn, 2008). 
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2.4.1 Nucleic acid extraction  
The quality of nucleic acids (DNA and RNA) extracted from digesters is crucial to 
subsequently obtain informative results. The extraction procedure has to be adapted 
and optimized for the type of samples under study. The first step in RNA and DNA 
extraction involves enzymatic digestion, or mechanical disruption of cells with a 
bead beater. Mechanical disruption in the presence of phenol is more convenient than 
enzymatic lysis of bacteria because nucleases are immediately destroyed. Many 
protocols have been published for the extraction of DNA from environmental 
samples and for co-extraction of  DNA and RNA  (Raskin, 1995;  Griffin, 1998;  
Ibrahim & Ahring, 1999). Extracted RNA should be stored at -80°C and extracted 
DNa may be stored at -20°C  (Talbot, 2008). 
2.4.2 Polymerase chain reaction (PCR) 
Copies of a specific DNA sequence are necessary for many molecular procedures, 
and the polymerase chain reaction (PCR) is the method by which copies are made in 
vitro. The polymerase chain reaction can copy segments of DNA by a process called 
amplification, yielding large amounts of specific genes or other DNA segments for a 
host of applications in molecular biology. PCR makes use of the enzyme DNA 
polymerase, which naturally copies DNA molecules. PCR does not actually copy 
whole DNA molecules but amplifies stretches of up to a few thousand base pairs (the 
target) from within a larger DNA molecule (the template) (Madigan, et. al, 2009). 
Figure 2.8 summarized the steps in PCR amplification of DNA. 
2.4.3 Denaturing gradient gel electrophoresis 
The variable regions of the 16S rRNA genes of bacteria can be amplified by PCR 
from total genomic DNA and analyzed by DGGE. The DGGE technology is based 
on electrophoresis of PCR-amplified rRNA gene fragments in polyacrylamide gels 
containing a linearly increasing concentration of denaturant (Muyzer, 1993). 
Amplified DNA fragments may have the same length but with different basepair 
sequence and can be electrophoretically resolved, revealing the diversity of the 
microbial community. Amplified DNA fragments are separated by DGGE according 
to the sequence of the different DNA. This technology has been used widely in 
environmental microbiology to study diversity and populations’ relative abundance 
shifts  (Muyzer, 1999)  in complex systems, including manure (Leung and Topp, 
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2001) and anaerobic bioreactors (Liu et al., 2002; Roest et al., 2005; Connaughton et 
al., 2006; Miura et al., 2007).   
 
Figure 2.8 : The polymerase chain reaction (PCR) (Madigan et. al., 2009). 
2.4.4 Quantitative real-time PCR 
Once the genetic identification of key Bacteria and Archeae are done, or if candidate 
bacterial species that are suspected to be of interest in the study are characterized, the 
design of specific primers is possible for a quantitative monitoring of these 
microorganisms by real-time PCR technology. Assays quantifying functional 
microbial genes, such as mcrA gene coding for an enzyme found in all methanogens 
and responsible for the production of methane, can as well be developed to determine 
the presence of bacteria having a common role in a community (Talbot, 2008). 
In contrast to the conventional end-point detection PCR, quantitative real-time PCR 
(Q-PCR) technology is based on the detection of fluorescence during amplification 
of target DNA (Higuchi, 1993). 
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2.4.5 Cloning and sequencing 
Of all the molecular techniques, cloning and sequencing of the gene that codes for 
16S rRNA is still the most widely used in the field of microbial ecology. The 
microbial community composition has been commonly determined by constructing 
16S rRNA clone libraries (Roest, 2005). This methodology implies the extraction of 
nucleic acids, amplification and cloning of the 16S rRNA genes, followed by 
sequencing and finally identification and affiliation of the isolated clone with the aid 
of phylogenetic software (Figure 2.9). 
 
 
Figure 2.9 : Outline of the cloning procedure for studying a microbial community. 
The work cycle is as follows: (A) direct nucleic acid extraction, without 
the need for previous isolation of microorganisms; (B) amplification of 
the genes that code for  16S rRNA by polymerase chain reaction (PCR), 
commonly using universal primers for bacteria or archaea, resulting in a 
mixture of rDNA copies corresponding to the microorganisms present 
in the sample; (C) cloning of the PCR products obtained into a suitable 
high copy number plasmid and transformation of competent E. coli 
cells with this vector; (D) selection of transformed clones with an 
indicator contained in  the plasmid (the white colonies in the figure); 
(E) extraction of plasmid DNA; (F) sequencing of the cloned gene, 
creating a clone library; (G) determination of the phylogenetic 
affiliation of the cloned sequence with the help of dedicated computer 
programs (ARB, Seqlab, PAUP, PHYLIP)  (Sanz & Köchling, 2007). 
16S ribosomal DNA clone libraries are made from environmental samples by cloning 
PCR products from extracted DNA into plasmid vectors. In the anaerobic digestion 
research area, Archaea and Bacteria are both important, and both corresponding 
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clone librairies are made separately by choosing domain-specific PCR primer sets, 
during the initial PCR amplification step. Each clone then contains one rRNA gene 
that is present in the environmental sample  (Talbot, 2008). This cloning and 
sequencing approach was first reported by Giovannoni  (1990) in an analysis of the 
diversity of bacterioplankton in Sargasso Sea. 
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3.  MATERIALS & METHODS 
3.1 Experimental approach 
The aim of this thesis is determination the acute inhibitory effects of antibiotic 
mixtures on methanogenic pathway. Within this framework, in the first step a stock 
anaerobic sequencing batch (ASBR) reactor was operated for acclimation of 
biomass. 
In the second step, a series of batch tests were set-up to examine the short-term 
effects of antibiotic mixtures. Acclimated microbial culture was used as a seed for 
batch tests. In addition, a different concentration (1 – 250 mg/L) and combination of 
the selected antibiotics were used to inoculate the test bottles. Serum bottles were 
kept running for an observation period of eight – twelve days (according to the 
carbon source) for assessing short-term (acute) inhibitory impact. VFA 
concentrations measured at the beginning and at the end of the tests for monitoring 
substrate removal. Biogas productions were monitored during the test period. 
Additionally microbial characterization of the seed sludge was done by cloning-
sequencing. 
3.2 Seed sludge Characteristics 
Seed was obtained from a full-scale UASB reactor (with a volume of 490 m
3
) from a 
local alcohol distillery. The temperature and pH in the UASB reactor were 
maintained within the ranges of 32-35°C and 7.2-7.7 respectively. Total solid (TS) 
and total volatile solid (TVS) concentrations of the granular sludge was 42724 mg/L 
and 27211 mg/L, respectively.  
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3.3 Laboratory scale anaerobic sequencing batch reactor operation 
An anaerobic sequencing batch reactor (ASBR) with a total volume of 10 L was 
operated  at 35°C (Figure 3.1). The reactor was operated with a 24-hour cycle 
consisting of fill (10 min), react (22 h 45 min), settle (1 h) and decant (5 min) phases. 
The rector was mixed using a magnetic stirrer at 90 rpm. 
 
Figure 3.1 : Lab-scale ASBR  
The system was inoculated with an anaerobic sludge obtained from a full-scale 
mesophilic anaerobic contact reactor treating the wastewater of raki and fresh grape 
alcohol. The MLVSS concentration of the reactor was 12250 mg/L. The ASBR was 
fed a synthetic wastewater with a total chemical oxygen demand (COD) 6250 mg/L 
of COD equivalent substrate mixture. The organic components and concentration of 
model wastewater was given in Table 3.1. 
Table 3.1 : The components and concentrations of model wastewater 
Components COD (mg/L) 
Starch 2915 
Glucose 1865 
NaAcetate 330 
NaButyrate 460 
NaPropionate 680 
Total COD 6250 
 
The pH of the model wastewater was adjusted 7 through addition of NaOH and the 
pH in the reactor varied from 6.8 to 7.2. 
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The reactor was operated with an organic loading rate (OLR) of 1250 mg COD/L.d 
for the first 3 days of operation and then increased to 6250 mg/L.d in a stepwise 
manner. The solid retention time was approximately 30 days throughout the study 
and was calculated based on VSS loss in the effluent and removed during sampling 
with excess sludge. The hydraulic retention time was 2.7 days.  
Temperature, pH and gas production were monitored daily in situ. Duplicate samples 
were collected from the reactor for chemical and microbiological analysis.  
3.4 Acute Tests Set-Up 
Acute tests were performed based on specific methanogenic activity (SMA) 
principles were carried out by using the pressure transducer technique (Colleran, 
1992). Increase in headspace pressure was monitored in sealed bottles by the hand-
held pressure transducer (Lutron PM-9107, U.S.A.) which was capable of measuring 
the pressure in a range of 5-7000 mbar daily. The test medium and the trace element 
solution were prepared according to the OECD311 protocol under strict anaerobic 
conditions (2006). The constituents of the medium is given in Table 3.2 while the 
constituents of trace element solution is given in Table 3.3. 
Table 3.2 : The constituents of test medium 
Component Amount (g) 
Anhydrous potassium dihydrogen phosphate (KH2PO4)  
0.27 
Disodium hydrogen phosphate dodecahydrate 
(Na2HPO4.12H2O)  
1.12 
Ammonium chloride (NH4Cl)  
0.53 
Calcium chloride dihydrate (CaCl2.2H2O)  
0.075 
Magnesium chloride hexahydrate (MgCl2.6H2O)  
0.10 
Iron (II) chloride tetrahydrate (FeCl2.4H2O)  
0.02 
Resazurin (oxygen indicator)  
0.001 
Sodium sulphide nonahydrate (Na2S.9H2O)  
0.10 
Stock solution of trace elements 
10 ml 
Add de-oxygenated water  
to 1 liter 
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Table 3.3 : The constituents of trace element solution 
Component Amount (mg) 
Manganese chloride tetrahydrate (MnCl2.4H2O)  50 
Boric acid (H3BO3) 5 
Zinc chloride (ZnCl2)  5 
Copper (II) chloride (CuCl2) 3 
Disodium molybdate dihydrate (Na2MoO4.2H2O)  1 
Cobalt chloride hexahydrate (CoCl2.6H2O)  100 
Nickel chloride hexahydrate (NiCl2.6H2O)  10 
Disodium selenite (Na2SeO3)  5 
Add de-oxygenated water  To 1 liter 
Glass serum bottles with 120 ml total volume sealed with butyl rubber septa and 
aluminium crimped were used in the tests. Liquid  volume was 100 ml and the 
headspace volume was 20 ml (Figure 3.2). 1000 mg/L VSS were added to the serum 
bottles. Acclimated biomass was sampled from the ASBR. Acute tests were 
organized based on a three-way factorial design where one factor was the 
composition of the substrate solution, another factor was the composition of 
antibiotic mixtures and the last factor was concentration of antibiotics added. Three 
different substrate solutions which were acetate, butyrate, and volatile fatty acid 
(VFA) mixture were used in the tests. Test conditions are given in Table 3.4. Firstly, 
substate concentrations in different concentrations (500, 1000, 1500, and 2000 mg/L) 
were tested in order to reach maximum potential methane production (PMP) rate 
during the batch tests. Thus the optimum substrate concentrations were determined. 
 
Figure 3.2 : 120 mL serum bottle with 100 mL active volume used for tests. 
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Among those 1500 mg/L were found to be optimum for each substate solutions 
(acetate, butyrate and VFA mixture). Acute tests were performed in duplicate  
bottles. The control bottles, which only included acetate, butyrate, or VFA mixture, 
were also set-up. During the test period, the bottles were stored at 35±2°C. 
Headspace pressure was measured by hand-held pressure transducer (Lutron PM-
9107, U.S.A.) and the bottles were shaken by hand everyday. The percentage of 
inhibition of biogas production was calculated from the amount produced in the 
respective test and control bottles. 
Table 3.4 : Test conditions for determining the acute effects of two or three 
                         component antibiotic mixtures                                                                   
 
ANTIBIOTIC CONCENTRATIONS (mg/L) 
SUBSTRATE TET ERY SMX 
Acetate (1500 mg/L)/ 
Butyrate (1500 mg/L)/ 
     VFA mixture (1500 mg/L) 
1 1 x 
1 x 1 
x 1 1 
Acetate (1500 mg/L) / 
Butyrate (1500 mg/L) / 
     VFA mixture (1500 mg/L) 
10 10 x 
10 x 10 
x 10 10 
Acetate (1500 mg/L) / 
Butyrate (1500 mg/L) / 
     VFA mixture (1500 mg/L) 
25 25 x 
25 x 25 
x 25 25 
Acetate (1500 mg/L) / 
Butyrate (1500 mg/L) / 
     VFA mixture (1500 mg/L) 
50 50 x 
50 x 50 
x 50 50 
Acetate (1500 mg/L) / 
Butyrate (1500 mg/L) / 
     VFA mixture (1500 mg/L) 
100 100 x 
100 x 100 
x 100 100 
Acetate (1500 mg/L) / 
Butyrate (1500 mg/L) / 
     VFA mixture (1500 mg/L) 
250 250 x 
250 x 250 
x 250 250 
Acetate (1500 mg/L) / 
Butyrate (1500 mg/L) / 
     VFA mixture (1500 mg/L) 
1 1 1 
10 10 10 
25 25 25 
50 50 50 
100 100 100 
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In the scope of the study 144 test bottles were set-up having three different substrate 
solutions, various combinations and concentrations of antibiotic mixtures. After the 
test period, samples were taken for chemical and microbial analysis.  
3.5 Chemical analysis and Analytical techniques 
Suspended solids (SS), volatile suspended solids (VSS), total suspended solids (TS), 
total volatile suspended solids (TVS), alkalinity and soluble COD were carried out  
according to American Public Health association APHA, 2005. Miligas Counter (Ritter 
Digital Counter, U.S.A.) was used for monitoring the biogas production in the stock 
reactor. Gas compositions and VFA concentrations were determined using gas 
chromatograph (Perichrom, France and Agilent Technologies 6890N, USA, 
respectively). 
3.6 Microbial Characterization  
The samples were taken from seed sludge for DNA extraction as triplicate.  The 
samples were stored at -20ºC until DNA extraction. 
3.6.1 Genomic DNA (GDNA) extraction 
Genomic DNAs were extracted using GF-1 Bacterial DNA Extraction Kit according 
to the manufacturer's instructions (GeneON, Germany). The concentrations of 
extracted GDNA were determined Qubit 2.0 Flouremeter (Invitrogen, UK). Then 
GDNA were diluted to 25 ng/µl by DNase free water. and stored at -20 ºC until the 
further analysis., 
3.6.2 Polymerase chain reaction (PCR) of 16S rDNA 
Amplification of 16S rDNA was performed by PCR using bacterial and archaeal 
specific primers. Bac8f-Bac1541r primers were used for the amplification 16S rDNA 
of bacteria, while Arch07f- Arch1384r primers were used for the amplification of 
Archaea. The primers and annealing temperatures are given in Table 3.5. Extracted 
GDNA was used as a template.  
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Table 3.5 : Bacterial and archaeal primers used for PCR amplification 
Primer Target 
Experimental Annealing 
(°C) 
Position
1
 Reference 
Stage 
Bact8f Bacterial 16S 
rDNA 
Cloning 55 
8-27 
Lane, 1991 
Bact1541r 1541-1522 
Arch7f 
Archaeal 16S 
rDNA 
Cloning 53 
07-24 Raskin et al., 1994 
Arch1384r 1384-1368 Lueders et al., 2004 
M13f 
B-galactosidase 
Clone 
screening 
54 – Schrenk et al., 2003 
M13r 
PCR reactions were performed in a 50 μl total volume including  25ng of DNA, 10 
pmol of each primer , 40 mM of each deoxynucleoside triphosphate, 5 μl of 10×Taq 
buffer and 10 U of Maximo Taq DNA polymerase (GeneON, Germany). 
Amplification was performed with a TECHNE-TC 412 thermal cycler. Reactions had 
an initial denaturation step at 94°C for 10 min, followed by 30 cycles of denaturation 
step at 94°C for 45 sec, annealing step at 53°C for 1 45 sec, and extension step at 
72°C for 2 min and a final extension step at 72°C for 10 min. All PCR products were 
run on the %1 (w/v) agarose gel stained with sybrgreen in 1x Tris-acetate-EDTA 
(TAE) buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA; pH 8) at 7 V cm-1 by 
electrophoresis (Invitrogen, UK). Gels were visualized by using a gel documentation 
system, Vilber Lourmat. 
3.6.3  Cloning, sequencing and phylogenetic analysis 
The bacterial and archaeal PCR products of the seed sludge of acute tests obtained 
using Bact8f-Bact1541r and Arch344f-Arch855r, respectively, were cloned by 
TOPO TA cloning kit (Invitrogen Ltd.,
 
UK) according to manufacturer's instructions. 
Before cloning, the PCR products were purified by PCR Clean-up Kit (GeneOn, 
Germany). To select the positive ones, 75 clones were collected from bacteria clone 
library and 83 clones were collected from archaea clone library. Colony PCR were 
applied using the vector-specific primers M13f and M13r. Bact341f_GC- Bact534r 
and Arch344f_GC-Univ522r primers were used to re-amplify positive bacterial and 
archaeal inserts, respectively. The re-amplified PCR products were analysed by high 
resolution melt (HRM) to select the respresentative OTUs. Then, the PCR products 
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to be sequenced were purified by ethanol precipitation and sequenced using the ABI 
prism Big Dye Terminator Cycle Sequencing Ready Reaction Kit on an ABI Prism 
377 DNA sequencer (Applied Biosystems, USA) using primers Bact342f and 
Arc344f generating 500bp and 800bp of bacterial and archaeal sequence
 
data, 
respectively. 
Partial 16S rRNA gene sequences were analyzed and manually edited in Amplify 3X 
software package version 3.14 (http://engels.genetics.wisc.edu/amplify). Homology 
searches of the EMBL and GenBank DNA
 
databases for the 16S rRNA gene 
sequences were performed with BLAST provided by the European Bioinformatics 
Institute (http://www.ebi.ac.uk/fasta33/nucleotide.html) to identify putative close 
phylogenetic relatives.
 
Sequence data were aligned by ClustalW tool at website of 
European Bioinformatics Institute. Distance analyses using the Jukes and Cantor 
(1969) correction and bootstrap resampling (1000 times) were done using the MEGA 
Software package version 5.1 (http:// http://www.megasoftware.net/) and trees were 
generated from distance matrices using the neighbour-joining method (Saitou and 
Nei, 1987).  
16S rRNA gene sequences showing 99% similarity or higher were considered to 
belong to the same phylotype. Related 16S rRNA gene sequences were placed within 
tentative taxa (between Phylum and Order) by determining the taxonomic class 
(using the NCBI taxonomy database) of the closest relative in GenBank of sequences 
that formed a phylogenetic clade. Sequences that showed no or low (below 70%) 
relateness with known bacterial or archaeal phylogenetic groups were listed as 
unclassified. Coverages of the clone libraries were calculated as 1 – (n1/N), where n1 
is the number of clone types that was encountered only once in the library and N is 
the total number of clones analyzed (Good 1953).  
3.7 Statistical Analysis 
Statistical analyses were made by using SPSS programme. One-way ANOVA test 
was applied to determine the significant inhibition of antibiotic mixtures on the total 
methane production and VFA utilization. 
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4.  RESULTS AND DISCUSSION 
4.1 Stock Anaerobic Sequencing Batch Reactor 
The ASBR was operated as a stock reactor for further analysis, fed a synthetic 
wastewater including starch, glucose, butyrate, propionate and acetate with an 
organic loading rate 6250 mg COD/L. Each step of the anaerobic treatment was set 
to run with this substrate solution, thus the specific inhibition step could easily 
investigate. 
The reactor was operated with 2.7 day HRT and short settling time (5 min) resulted 
in good biomass settling conditions and low effluent suspended solids. Prior the 
steady-state condition, the influent COD was increased in a stepwise manner from 
1250 mg/L COD to 6250 mg/L COD. At steady-state, it exhibited a stable 
performance, with an average effluent soluble COD of 475±50 mg/L corresponding 
to a COD removal of around 93% (Figure 4.1) and an average biogas production of 
13,01±1,27 L/d.During this period, the methane content in the biogas averaged 
75±1.4%.  
 
Figure 4.1 : Influent and effluent soluble COD concentration of stock ASBR. 
0
1000
2000
3000
4000
5000
6000
7000
1 2 3 4 5 6 7 8 9 101112131415161718192021222324252627
C
O
D
  (
m
g/
l)
 
Days of operation 
Influent COD (mg/l)
Effluent COD (mg/l)
42 
4.2 Characterization of Seed Sludge 
Seed sludge which used in acute tests was characterized in terms of potential 
methane production capacity and dominant microbial species. Spesific methanogenic 
activity (SMA) test was applied to determine the potential methane production 
capacity of the seed sludge. For the microbial characterization, bacterial and archaeal 
16S rDNA clone libraries were constructed. HRM analysis was applied to compare 
the detected microbial species by clone libraries to all OTUs in the sludge samples.  
4.2.1 Specific methanogenic activity (SMA) test 
Methanogenic characteristics of seed sludge were investigated by specific 
methanogenic activity (SMA) tests. SMA tests with acetate concentration between 
1000-5000 mg/L were set up for determination of acetoclastic methanogenic activity. 
To determine the maximum methane production capacity of seed sludge, VFA 
mixtures (acetate, propionate, butyrate) were used as substrate for SMA tests. 3000 
mg/L of acetate and 4000 mg/L of VFA mixture were found as optimum 
concentrations for the next analysis. 
4.2.2 Bacterial and archaeal 16S rDNA clone libraries 
Bacterial and archaeal 16S rDNA gene clone libraries were constructed from the 
seed sludge for characterization of microbial community structure. 
All clones were screened by HRM analysis and this analysis showed that 12 different 
OTUs were obtained from 75 bacterial clones and 22 different OTUs were found in 
83 archaeal clones. Table 4.1 and 4.2, shows all different OTUs were sequenced and 
the closest relatives of bacterial and archaeal sequencing results respectively. 
As seen in Figure 4.2. 64% of the bacterial clone library were composed of 
unclassified bacteria. The most abundant classified phylum was Firmicutes (21%). 
The members of Actinobacteria and Cyanobacteria were distributed as 11% and 4%, 
respectively. Clostridium sp., were represented  93% of  Firmicutes members in the 
seed sludge. 
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Figure 4.2 : Distribution of phylogenetic phylums from clone sequence of bacterial 
                           16S rDNA clone library. 
The dominant Firmicutes OTU was 07a (JF946895) and it represented %12 of all 
bacterial clones. It is most closely related to the Clostridium sp. L35B_99 isolated 
from mesophilic and thermophilc methanogenic enrichment that degrades petroleum 
hydrocarbons (Cheng & Lu, 2011). Other OTU related to Firmicutes phylum was 
05a, mostly closed to isolate from oil well by Pham et al. (2009). 
Actinobacteria was the second abundant phylum  (11%) of the bacterial clone library 
which are responsible to produce of propionic acid, acetic acid and carbon dioxide 
(Madigan et al., 2009). The dominant OTU was 09c (HM480642), represents 8% of 
all bacterial clones. It is mostly related to an uncultured actinobacterium clone 
O_1H06 obtained from meadow soil (Sagova-Mareckova, et al., 2011). Other OTU 
in Actinobacteria phylum was 10b (JQ217228). It is most closely related to an 
uncultured Brachybacterium sp. clone OTU116 obtained from marine sediment (Yan 
et al., 2011).  
Cyanobacteria phylum represented 4% of the bacterial clone library. It was most 
closely related to an uncultured  Plectonema sp. clone 2K79 which was isolated from 
groundwater (Aizenberg-Gershtein et al., 2012). 
The phylogenetic tree constructed by bacterial clones was given in Figure 4.3.  
 
 
4% 
64% 
21% 
11% 
Cyanobacteria
Unclassified Bacteria
Firmicutes
Actinobacteria
44 
Table 4.1 : Affiliation of bacterial clones and their abundance in the seed sludges. 
Clon Name 
Clone 
Frequency 
(%) 
Accession No Closest Relative Similarity 
01a 
0,0135 
GU074264 Uncultured Plectonema sp. clone 2K79  100 
01b 
0,0135 
GQ091211 Uncultured bacterium clone nbw343d12c1 97 
01c 
0,0135 
GU074264 Uncultured Plectonema sp. clone 2K79  95 
02a 
0,0135 
GU074264 Uncultured Plectonema sp. clone 2K79  99 
03a 
0,0270 
GQ091211 Uncultured bacterium clone nbw343d12c1  91 
03b 
0,0135 
GQ091212 Uncultured bacterium clone nbw343d12c1  89 
04a 
0,0270 
JF946895 Uncultured Clostridia bacterium clone L35B_99  94 
05a 
0,0135 
GU179924 Uncultured Firmicutes bacterium clone D120231B11  97 
06a 
0,0135 
JF946895 Uncultured Clostridia bacterium clone L35B_99  94 
07a 
0,1216 
JF946895 Uncultured Clostridia bacterium clone L35B_99  96 
07b 
0,0135 
JF946894 Uncultured Clostridia bacterium clone L35B_105  94 
08a 
0,0135 
JN680632 Uncultured Clostridiaceae bacterium clone SL89  100 
08b 
0,0135 
DQ125557 Uncultured bacterium clone AKAU3538  97 
09a 
0,1757 
FQ658959 Uncultured bacterium clone M1CB122 95 
09b 
0,2838 
HM823586 Uncultured bacterium clone nby472e12c1  94 
09c 
0,0811 
HM480642 Uncultured actinobacterium clone O_1H06 97 
09d 
0,0135 
JN397736 Uncultured bacterium clone BSB0103-03 96 
10a 
0,0405 
HQ393224 Uncultured bacterium clone 4.19  95 
10b 
0,0270 
JQ217228 Uncultured Brachybacterium sp. clone OTU116  96 
10c 
0,0135 
JN521901 Uncultured organism clone SBZI_3837  96 
11a 
0,0405 
FN563168 Uncultured bacterium clone HAW-RM37-2-B-650d-A3 100 
12a 
0,0135 
AB291266 Uncultured bacterium clone: SmB7 95 
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Figure 4.3 : Neighbor-joining full-length 16S rDNA trees showing the genetic    
                           distances among individual clones from bacterial 16S rDNA clone     
                           library. Tha bar scale represents 5 nucleotide substitutions per 100 
                           nucleotides. 
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Methanosarcinales (27%)  is the most abundant classified phylum of archaeal clone 
library of seed sludge. This rate is important cause, nearly 70% of total methane 
produce from acetate by acetoclastic methanogens (Gujer & Zehnder, 1983). 
Methanosarcina and Methanosaeta (previously known as Methanothrix) are the two 
major genera of acetoclastic methanogens. Methanosarcina uses several 
methanogenic substrates such as methanol, methylamines, and sometimes H2/CO2. 
Methanosaeta can only grow on acetate (Khanal, 2008). As it is shown in Table 4.2, 
both of these generas were detected in the seed sludge.  
The members of unclassified archaea, euryarchaeota and Methanomicrobiales were 
distributed as 58%, 8% and 7% respectively (Figure 4.4). 
 
Figure 4.4 : Distribution of phylogenetic phylums from clone sequence of archaeal 
                           16S rDNA clone library. 
The dominant Methanosarcinales OTU, 02a (JQ684643), related cluster, represented 
by 7,23% of all archaeal clones. It was mostly closed to an uncultured Methanosaeta 
sp. clone JM-ASBR-Arch-117 (Ma et al., 2012). Other OTUs of this phylum were 
isolated from anaerobic sludge samples and tidal flat sediments. The OTU, 01b 
(X51423) was most closely related (95%) to Methanothrix soehngeni, which utilizes 
acetate for production of methane (Eggen et al.,1991). 
The dominant Methanomicrobiales OTU, 12a (M59143), related cluster, represented 
by 4,81% of all archaeal clones was most closely related (100%)  to Methanoplanus 
limicola (Rouviere et al., 1992). 
27% 
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7% 
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Methanosarcinales
Unclassified Archaea
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Euryarchaeota
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OTUs including the members of euryarchaeota and unclassified archaea were 
isolated from lake sediment, mesophilic anaerobic digester which treats municipal 
wastewater sludge, rich minerotrophic fen, and compost (Fan & Wu, 2011; Riviere, 
et al., 2009; Cadillo-Quiroz et al.,2008; Lee et al., 2006). The phylogenetic tree 
constructed by archaeal clones was given in Figure 4.5.  
Table 4.2 : Affiliation of archaeal clones and their abundance in the seed sludges. 
Clone 
Name 
Clone 
Frequency 
(%) 
Accession 
No 
Environmental Database Similarity 
01a 0,0120 JF947134 Uncultured Methanosaeta sp. 97 
01b 0,0120 X51423 Methanothrix soehngenii 95 
02a 0,0723 JQ684643 Uncultured Methanosaeta sp. 89 
03a 0,0120 FR823806 Uncultured archaeon clone arch.R1-49 92 
04a 0,0241 JQ684642 Uncultured Methanosaeta sp. clone JM-ASBR-Arch-116 92 
04b 0,0120 JQ684638 Uncultured Methanosaeta sp. clone JM-ASBR-Arch-112 92 
05a 0,0361 JQ684588 Uncultured Methanosaeta sp. clone JM-ASBR-Arch-60 96 
06a 0,0241 JN617394 Uncultured archaeon clone A2-66 93 
06b 0,0361 JQ684600 Uncultured Methanosaeta sp. clone JM-ASBR-Arch-73 95 
06c 0,0241 JQ684605 Uncultured Methanosaeta sp. clone JM-ASBR-Arch-78 92 
07a 0,0241 JQ684643 Uncultured Methanosaeta sp. clone JM-ASBR-Arch-117 91 
07b 0,0843 JN397898 Uncultured archaeon clone SSA0402-03 93 
08a 0,0241 CU917427 Uncultured Methanosarcinales archaeon clone QEEG1AC031 92 
08c 0,0120 JN617394 Uncultured archaeon clone A2-66 97 
09a 0,0241 CU916696 Uncultured Methanosarcinales archaeon clone QEEG1AC031 92 
10a 0,0241 HM061282 Uncultured archaeon clone Arch.a24.46 97 
10b 0,0120 EU156000 Methanosphaerula palustris 95 
10c 0,0120 EU156000 Methanosphaerula palustris 94 
11a 0,0602 CU915960 
Uncultured Methanomicrobiales archaeon clone 
QEEL1CB101 
81 
12a 0,0482 M59143 Methanoplanus limicola 100 
12b 0,0120 M59144 Methanoplanus limicola 100 
13a 0,0120 JN173203 Uncultured Methanogenium sp. clone A673 100 
14a 0,0241 M59134 Methanogenium marisnigri 97 
15a 0,0482 M59147 Methanocorpusculum parvum 97 
16a 0,0241 JQ179819 Uncultured archaeon clone C4TRA06 98 
17a 0,0241 JQ179798 Uncultured archaeon clone C4ALB04 98 
18a 0,0241 DQ365140 Uncultured compost archaeon clone 4A01 95 
19a 0,1807 CU917453 
Uncultured Methanomicrobiales archaeon clone 
QEEC1DA051 
97 
20a 0,0482 CU917453 
Uncultured Methanomicrobiales archaeon clone 
QEEC1DA051 
100 
21a 0,0241 CU915998 
Uncultured Methanomicrobiales archaeon clone 
QEEK1BA061 
97 
22a 0,0120 CU917453 
Uncultured Methanomicrobiales archaeon clone 
QEEC1DA051 
92 
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Figure 4.5 : Neighbor-joining full-length 16S rDNA trees showing the genetic   
                           distances among individual clones from archaeal 16S rDNA clone 
                           library. Tha bar scale represents 2 nucleotide substitutions per 100 
                           nucleotides. 
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4.3 Acute Tests 
Acute tests were designed to evaluate short-term inhibitory effect of the multi-
component mixture of selected antibiotics, tetracycline (TET), sulfamethoxazole 
(SMX), and erythromycin (ERY) on the metabolic activity of both homoacetogens 
and methanogens, which are specific trophic groups in the acclimated sludge. The 
experiments were designed as three sets which were differ according to the substrate 
composition (acetate, butyrate and VFA mixtures). Antibiotic concentrations were 
between 1-250 mg/L at different mixture composition. 
The test bottles were monitored by the parameters in terms of biogas/methane 
production and VFAs removal. Biogas generation was monitored daily throughout 
the experiment period. VFA concentrations were measured at the end of the test. 
A preliminary test was conducted before the inhibition experiments, mainly to 
determine the optimum initial dose of acetate, butyrate, and VFA mixture. For this 
purpose, initial substrate concentrations in the range of 500–2000 mg/L were tested 
in the control reactor without antibiotic addition and 1500 mg/L of each substrate 
was determined as the optimum initial dose. 
4.3.1 Acetate as a sole carbon source 
Acetate is a key intermediate in the anaerobic food chain. It  is estimated that nearly 70% 
methane is produced from acetate other than hydrogenotrophic pathway (Jones, 1991). 
Two genera of archaea, Methanosarcina and Methanosaeta, are known to use acetate as 
a substrate for methanogenesis. Methanosaeta uses only acetate for methane production, 
whereas Methanosarcina, utilizes both methylated compounds such as methanol and 
methylamines and acetate (Smith & Ingram-Smith, 2007).  
It was determined that Methanosarcinales (27%)  is the most abundant classified 
phylum of archaeal clone library of the seed sludge which includes Methanosarcina 
and Methanosaeta. Acetate tets bottles were set up to identify the inhibition effect of 
the antibiotic mixtures on acetoclastic methanogens. 
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4.3.1.1 Methane production 
Average of total methane production in the control bottles was 64 mL at the end of the 
test period which was 95% of total biogas production. Figures 4.6 - 4.10 indicate 
total and maximum methane productions of the test bottles with acetate and different 
antibiotic combinations. The complete inhibition was observed in none of the test 
bottles.  
Figure 4.6a reports the total methane production in the test bottles with the addition 
of three-component mixture (ETS) of antibiotics compared with the control bottles. 1 
mg/L antibiotic mixture added test bottles showed nearly the same pattern with 
control bottles. The significant inhibition effect induced when ETS dosage was 
increased up to 50 mg/L where the total methane production decreased to 32 mL. 
The maximum inhibition effect was observed at 100 mg/L concentration. The 
methane production was 17 mL at 100 mg/L ETS concentration.  
Figure 4.6b indicates the maximum methane production profile. The maximum 
methane production  was 220 mL CH4/gVSS.day  in control bottles. A slight 
decrease was observed at 1 mg/L concentration, maximum methane production was 
decreased to 130 mL CH4/gVSS.day at this concentration. 25 – 50 mg/L 
concentrations showed nearly the same pattern with each other.  At 100 mg/L 
concentration, the maximum methane production was 34 mL CH4/gVSS.day, which 
was 85% lower than control bottles. 
There was a significant correlation between the total methane production and antibiotic 
concentration according to Pearson’s correlation (p<0,01).  
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Figure 4.6 : Inhibition effect of ETS dosage on (a) total methane production, (b) 
                           maximum methane production when acetate as a sole carbon source. 
Figure 4.7 shows the effects of ET mixture on total and maximum methane 
production. ET mixture indicated quite similar methane profile to control bottles at 1 
mg/L. The profiles associated with 10 – 25 mg/L indicated similar pattern with each 
other. Significant decreases were observed at concentrations between 100 – 250 
mg/L. The maximum methane production of sludge was decreased significantly at 
100 mg/L ET concentration (Figure 4.7b). At 250 mg/L, maximum methane 
production was decreased to 31 CH4/gVSS.day. 
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Figure 4.7 : Inhibition effect of ET dosage on (a) total methane production, (b) 
                           maximum methane production when acetate as a sole carbon source. 
The  effects of ST mixture on total methane production were shown in Figure 4.8a. 
Significant inhibition effect was induced at 250 mg/L. The methane content of biogas 
composition was decreased (92% – 75%) with increasing antibiotic concentration (1 
– 250 mg/L). There were no significant difference between the concentration 1-25 
mg/L on maximum methane production of sludge (Figure 4.8b). A slight decrease on 
maximum methane production was observed at 250 mg/L ST concentration. There 
was nearly no methane production at this concentration. 
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Figure 4.8 : Inhibition effect of ST dosage on (a) total methane production, (b) 
                           maximum methane production when acetate as a sole carbon source. 
As shown in Figure 4.9a ES mixture indicated nearly similar pattern at 1 – 50 mg/L 
concentrations. The inhibition effect was seen clearly at 100 mg/L. Maximum 
inhibition effect was seen at 250 mg/L ES concentration. Figure 4.9b shows the 
changes on maximum methane production of sludge with ES addition. The same 
pattern was seen at 1 – 100 mg/L concentrations on maximum methane production of 
sludge.  
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Figure 4.9 : Inhibition effect of ES dosage on (a) total methane production, (b) 
                           maximum methane production when acetate as a sole carbon source. 
Figure 4.10 shows the total and maximum methane production for all combinations 
of antibiotic mixtures. The highest inhibition effect of antibiotics on total methane 
production was observed at 250 mg/L ST mixture. In the study carried out by 
Gartiser et al. (2006) was indicated that, erythromycin and sulfamethoxazole had no 
inhibition effect on biogas production. Also Fountulakis and his colleaugues  stated 
that, sulfamethoxazole had not affected methanogenesis even at high concentrations 
(400 mg/L). While ET combinations constituted the lowest effect at 1 mg/L, it 
caused the highest inhibition effect at 10 mg/L and 100 mg/L. At 25 mg/L, ST 
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mixture caused the highest inhibition effect in all combinations of antibiotics. 
However, at 50 mg/L the highest decrease on the total methane production was 
caused by ETS mixture. Figure 4.10b indicates the effects of antibiotic mixtures on 
the maximum methane production rate. ETS mixture had the highest inhibition effect 
for all concentrations.   
 
 
Figure 4.10 : Inhibition effect of antibiotic mixtures on (a) total methane production, 
                             (b) maximum methane production when acetate as a sole carbon    
                             source. 
The EC50 level is a commonly used parameter for inhibitory impact which defined as 
the inhibitor concentration, induces 50% inhibition on measured response of the 
microbial community (Ruiz et al., 2009). The corresponding EC50 values were 
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calculated as 50 mg/L for ETS, 65 mg/L for ET, 102 mg/L for ST, and 138 mg/L for ES. 
In a study carried out by Cetecioglu and her colleagues (2012), reported that EC50 levels 
of single compounds were 155.4 mg/L for ERY, 204.4 mg/L for TET, and 198.5 mg/L 
for SMX. It was determined that, antibiotic mixtures had the lower EC50 values than 
single compounds.  
4.3.1.2 Utilization of volatile fatty acids 
Initial acetate concentrations in all serum bottles were 1500 mg/L. Acetate 
accumulation was observed in all antibiotic added reactors (Figure 4.11). Amin et al. 
(2006) evaluated the effects of erythromycin on the removal of acetic acid. It was 
stated that, even in the presence of high concentrations of erythromycin was not 
inhibit the acetic acid removal. However, antibiotic mixtures including erythromycin 
caused the acetic acid accumulation after 50 mg/L. At 50 mg/L concentration, ETS 
mixture showed the highest inhibitory effect on acetate removal. At 100 mg/L 
concentration ET mixture had the highest acetic acid concentrations at the end of the 
test period. On the other hand, at 250 mg/L ST containing bottles  caused the highest 
acetic acid accumulation. 
Acetic acid was negatively correlated with total methane production (p<0,01) but, it 
was positively correlated with antibiotic concentration (r=0,889; p<0,01).  
 
Figure 4.11 : VFA concentration in effluents of acetate set. 
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4.3.2 Butyrate as a sole carbon source 
Volatile fatty acids (butyrate, propionate etc.) are not directly used by methanogens. 
They serve as substrates for proton reducing syntrophic bacteria. Different groups of 
syntrophic bacteria use specific VFAs and accumulation of these VFAs give 
information about sensitivity of relavant syntrophic bacteria to antibiotics (Amin et 
al., 2006). In this direction, butyrate was selected as a sole carbon source to examine 
the inhibition effects of selected antibiotic mixtures on different microbial 
populations.  
Degradation of butyrate is carried out by Gram positive beta-oxidizing syntrophic 
bateria (e.g., Syntrophomonas spp. And Syntrophospora spp.) (Shimada et al., 2008). 
Syntrophomonas is belong to the Firmicutes phylum which was comprised 21% of 
seed sludge’s bacterial 16S rDNA clone library.  
4.3.2.1 Methane production 
Figures 4.12 - 4.16 indicate the total and maximum methane production for different 
combination of antibiotic mixtures, which contain butyrate as a sole carbon source. 
At the end of the test period, average total methane production in the control bottles 
was 102,5  mL which was the 93% of total biogas production. None of the tested 
antibiotic mixtures completely inhibited biogas production.  
As shown in Figure 4.12a ETS mixture indicated nearly a similar pattern at 1-10 
mg/L and 25 – 100 mg/L concentrations. The methane content of biogas decreased 
from 88% to 80% with increasing antibiotic concentration from 1 mg/L to 100 mg/L. 
On the other hand, there was a significant decrease occurred on maximum methane 
production by ETS mixture addition (Figure 4.12b). Significant decrease was 
observed after 10 mg/L concentration. While, maximum methane production was 
167 mL CH4/g VSS.day, this value was decreased to 84 mL CH4/g VSS.day at 10 
mg/L ETS concentration. At 100 mg/L, maximum methane production was 65 mL 
CH4/g VSS.day. 
58 
 
 
Figure 4.12 : Inhibition effect of ETS mixture dosage on (a) total methane 
                             production (b) potential methane production when butyrate as a sole  
                             carbon source. 
In ET mixture, there was no significant inhibitory effect like in ETS mixture for 
tested concentrations (Figure 4.13a). Increasing in the antibiotic concentration caused 
to a decrease in the total methane production, but decrease level was not remarkable. 
According to Amin and his colleagues (2006), ERY had a substantial effect on 
butyrate utilization as well as methane production rate. However, in our study 
significant inhibition effect was not detected in all tests that included ERY. It is 
suggested that, antagonistic effects were occurred in tested antibiotic mixtures. 
Christensen et al. (2006) reported that, synergistic effects were seen in the mixture 
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oxytetracycline and erythromycin, while antagonistic effects were observed in the 
tests that included flumequine - erythromycin and flumequine - oxytetracycline 
mixtures.The methane ratio in the biogas decreased from 93% to 86% with 
increasing the ET concentration. However, as in the ETS mixture, there was a slight 
decrease on the maximum methane production with antibiotic mixture addition 
(Figure 4.13b). While the maximum methane production was 166,4 mL CH4/g 
VSS.day in the control bottles, this value was decreased to 68 mL CH4/g VSS.day at 
250 mg/L ET concentration. 
 
 
Figure 4.13 : Inhibition effect of ET mixture dosage on (a) total methane production 
                             (b) potential methane production when butyrate as a sole carbon 
                             source. 
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For ST mixture, 1 mg/L concentration showed nearly the similar pattern with control 
bottle (Figure 4.14a). 10 – 50 mg/L concentrations indicated a similar trend with 
each other. The significant decrease on the total methane production was induced 
after 100 mg/L. Methane percentage in the biogas decreased from 93% to 88%. The 
maximum methane production profile indicated similar pattern with ET mixture 
(Figure 4.14b). The significant inhibitory effect was started at 1 mg/L concentration. 
At 250 mg/L, the maximum methane production was 49,5 mL CH4/g VSS.day.  
 
 
Figure 4.14 : Inhibition effect of ST mixture dosage on (a) total methane production 
                             (b) potential methane production when butyrate as a sole carbon    
                             source. 
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Figure 4.15 shows the inhibition effect of ES mixture on the total and maximum 
methane production. Total methane production of the test bottles with 1 mg/L of ES 
mixture was close to the control bottles like in ST mixture. There was no slight 
decrease with increasing the antibiotic concentration. However after the mixture 
dosage increased to 100 – 250 mg/, the inhibitory effect can be seen clearly. The 
maximum methane production was decreased in stepwise manner with increasing 
antibiotic concentration. 
 
 
Figure 4.15 : Inhibition effect of ES mixture dosage on (a) total methane production 
                             (b) maximum methane production when butyrate as a sole carbon 
                             source. 
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Inhibition effects of all antibiotic mixtures on the total and maximum methane 
production was shown in Figure 4.16. At the 1 – 25 mg/L antibiotic concentrations, 
ETS mixture caused the highest inhibitory effect on the total methane production. At 
50 mg/L the highest decrease on the total methane production caused by ES mixture. 
At 100 – 250 mg/L ST mixture indicated the highest inhibitory effect on the total 
methane production.  
 
 
Figure 4.16 : Inhibition effect of all antibiotic mixtures  (a) on total methane 
                              production, (b) maximum methane production while butyrate as a sole 
                             carbon source. 
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The EC50 levels were determined just for ST mixture (96 mg/L). For other mixtures, 
EC50 values were predicted above the tested antibiotic concentrations.  
There was a significant correlation between the total methane production and 
antibiotic concentration according to Pearson’s correlation (p<0,01; r=-0,703).  
4.3.2.2 Utilization of volatile fatty acids 
Initial butyrate concentrations in all serum bottles were 1500 mg/L. As seen in the 
Figures 4.17 – 4.20, VFA accumulation was occurred with increasing antibiotic 
concentration. There was a significant correlation between total methane production 
and butyric acid concentration (p<0,01; r=-0,99). According to Pearson’s correlation, 
propionic acid, isobutyric acid, and isovaleric acid were also significantly correlated 
with total methane production (p<0,01). Amin and his colleagues (2006) stated that, 
the erythromycin addition had a substantial effect on the removal of butyric acid 
even at lower concentrations. They pointed out that, butyrate is used by bacteria, and 
erythromycin is more effective against Gram-positive bacteria. 
Figure 4.17 indicates VFA concentrations for ETS mixture. A slight increase in VFA 
concentration was observed at 25 mg/L ETS included test bottles where butyric acid 
accumulation was higher than other bottles. Cetecioglu (2011) found that, VFA 
accumulation started after 250 mg/L for SMX and ERY whereas it observed in TET 
bottles after 25 mg/L. After 100 mg/L, acetic acid, isobutyric acid and propionic acid 
accumulations were increased.  
 
Figure 4.17 : VFA concentration in effluents of  ETS mixture while butyrate as the 
                             sole carbon source. 
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In ET mixture, VFA accumulation was increased significantly at 25 mg/L 
concentration like in ETS mixture (Figure 4.18). Butyric acid concentration was 
increased from 113 mg/L to 509 mg/L with increasing the antibiotic concentration 1 
– 250 mg/L. 
 
Figure 4.18 : VFA concentration in effluents of ET mixture while butyrate as the 
                             sole carbon source. 
Figures 4.19 – 4.20 indicate VFA concentrations for ST and ES mixtures, 
respectively. Significant VFA accumulation was started at 10 mg/L antibiotic 
mixture concentration both in ST and ES included test bottles. While there was a 
sudden increase in VFA concentration between 50 and 100 mg/L ST included test 
bottles, VFA accumulation was occurred in stepwise manner in ES set. 
 
Figure 4.19 : VFA concentration in effluents of  ST mixture while butyrate as the 
                             carbon source. 
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Figure 4.20 : VFA concentration in effluents of  ES mixture while butyrate as the 
                             carbon source. 
4.3.3 VFA mixture as a sole carbon source 
VFA mixture was used as substrate for evaluation both homoacetogens and all 
methanogens. Clostridium aceticum and Acetobacterium woodii are the two 
mesophilic homoacetogenic bacteria isolated from sewage sludge which are belong 
to the Firmicutes phylum (Novaes, 1986). Firmicutes phylum was comprised 21% of 
seed sludge’s bacterial 16S rDNA clone library.  
Acetoclastic methanogens are responsible nearly 70% of total methane generation. 
They are belong to the Methanosarcinales phylum, which is the most abundant 
classified phylum (27%) of the seed sludge’s archaeal clone library. 
Hydrogenotrophic pathway contributes up to 28% of the methane generation in 
anaerobic systems. Euryarchaeota and Methanomicrobiales were comprised 8% and 
7% of seed sludge’s archaeal clone library, respectively. 
4.3.3.1 Methane production 
There was a significant correlation between total methane production and antibiotic 
concentrations (p<0,01; r=-0,712). Figures 4.21 - 4.25 show the effects of antibiotic 
mixtures on the total and maximum methane production for the test bottles, which 
contain VFA mixtures as the sole carbon source. At the end of the test period, 
average of total methane production in the control bottles was 80,45  mL which was 
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the 93% of total biogas production. Complete inhibition on biogas production was 
not seen for the tested antibiotic concentrations.  
As seen in Figure 4.21a, test bottles with 1 mg/L concentration ETS mixture showed 
nearly the similar pattern with control bottles. The total methane production was 
decreased in stepwise manner with increasing the ETS dosage. The significant 
inhibition on total methane production was detected at 100 mg/L ETS concentration. 
On the other hand, significant decrease on maximum methane production was 
observed at 25 mg/L (Figure 4.21b).  
 
 
Figure 4.21 : Inhibition effect of ETS mixture dosage on (a) total methane 
                              production (b) maximum methane production when VFA mixture as a 
                             sole carbon source. 
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The effects of 10 – 100 mg/L ET mixture on total methane production was indicated 
nearly similar trend with each other (Figure 4.22a). Total methane production was 
decreased to 31,5 mL at 250 mg/L ET concentration. The methane content of biogas 
decreased from 87% to 69% with increasing ET concentration from 1 mg/L to 250 
mg/L. Significant decrease on maximum methane production was observed at 50 
mg/L concentration (Figure 4.22b). 
 
 
 
Figure 4.22 : Inhibition effect of ET mixture dosage on (a) total methane production 
                              (b) maximum methane production when VFA mixture as a solecarbon 
                             source. 
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For ST mixture, 1 – 10 mg/L concentrations indicated a similar trend with each other 
(Figure 4.23a). The significant decrease on total methane production was induced 
after  50 mg/L ST dosage. Methane percentage in the biogas decreased from 93% to 
85%. The maxium methane production was decreased in stepwise manner with 
decreasing the antibiotic concentration (Figure 4.23b). The significant inhibitory 
effect on maximum methane production was observed after 100 mg/L.  
 
 
 
 
Figure 4.23 : Inhibition effect of ST mixture dosage on (a) total methane production 
                              (b) maximum methane production when VFA mixture as a sole carbon 
                             source. 
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Figure 4.24a shows the inhibition effect of ES mixture on total methane production.  
Total methane production of the test bottles with 1 mg/L ES mixture was close to the 
control bottles. Inhibitory effect can be seen clearly at 10 mg/L. The test bottles, 
included between 10 – 250 mg/L ES, showed nearly the similar pattern with each 
other. The significant decrease on maximum methane production was detected at 250 
mg/L ES concentration. 
 
 
 
Figure 4.24 : Inhibition effect of ES mixture dosage on (a) total methane production 
                              (b) maximum methane production when VFA mixture as a sole carbon 
                             source. 
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Figure 4.25a shows the total methane production for all combinations of antibiotic 
mixtures. While ST mixture was induced the highest inhibition effect on total 
methane production at 1 – 25 – 50 mg/L concentrations, ETS mixture was caused the 
lowest effect. At 100 mg/L,  ETS and ST mixtures induced nearly the same 
inhibitory effect on total methane production. At 250 mg/L, ET and ST mixtures 
indicated nearly the same inhibitory effect. It was expected that, three component 
mixture would have the highest inhibitory effect, but results did not agree with that 
prediction. This result was agree with the study carried out by Al-Ahmad (2009). 
According to the study, the eleven component antibiotic mix, which included ERY 
and SMX, did not affect biodegradation performance of activated sludge. Figure 
4.25b shows the maximum methane production for all combination of antibiotic 
mixtures. At 1 – 10 mg/L, ET mixture caused the highest inhibition effect whereas 
ETS mixture induced the highest decrease between 25 – 100 mg/L concentrations.  
 
 
Figure 4.25 : Inhibition effect of all antibiotic mixtures  (a) on total methane 
                              production, (b) maximum methane production while VFA mixture as a 
                              sole carbon source. 
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The EC50 level is a commonly used parameter for inhibitory impact which defined as 
the inhibitor concentration, induces 50% inhibition on measured response of the 
microbial community (Ruiz et al., 2009). The corresponding EC50 values were 
calculated as 88 mg/L for ETS, 106 mg/L for ET, 52 mg/L for ST. EC50 value of ES 
mixture was predicted above the tested antibiotic concentrations.  
In a study carried out by Cetecioglu and her colleagues (2012), reported that EC50 levels 
of single compounds were 85.8 mg/L for ERY, 46.2 mg/L for TET, and 55.4 mg/L for 
SMX. EC50 values of single compounds were lower than all mixtures except ST mixture. 
EC50 value of ST mixture was lower than single SMX.  
4.3.3.2 Utilization of volatile fatty acids 
Initial VFA mixture (acetate, propionate, and butyrate) concentrations in all serum 
bottles were 1500 mg/L. VFA concentrations were shown in the Figures 4.26 – 4.29. 
According to Pearson’s correlation, acetic acid (r=-0,822), propionic acid (0,905), 
and butyric acid (0,946) were significantly correlated with total methane production 
(p<0,01).  
VFA concentration was increased in stepwise manner with increasing ETS 
concentration (Figure 4.26). At 250 mg/L ETS concentration, the highest 
accumulation of all VFAs was observed.  
 
Figure 4.26 : VFA concentration in effluents of  ETS mixture while VFA mixture as 
                             the sole carbon source. 
Figure 4.27 indicates the effect of ET mixture on VFAs concentrations. VFAs were 
started to accumulate after 1 mg/L ET addition. In the study carried out by 
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Cetecioglu (2011), VFA accumulation started after 250 mg/L for SMX and ERY. 
But in this study, it was clearly seen that VFA accumulation started even in the 
presence of low concentrations. Cetecioglu pointed out that, removal of acetic acid 
was not affected. The datas obtained from this study confirmed with this finding. 
 
Figure 4.27 : VFA concentration in effluents of  ET mixture while VFA mixture as 
                             the carbon source. 
A slight increase in VFA concentrations was observed at 1 mg/L ST included test 
bottles (Figure 4.28). In ES mixture, VFAs were started to accumulate after 10 mg/L. 
10 – 25 mg/L concentrations were indicated nearly similar trend with each other. 
 
Figure 4.28 : VFA concentration in effluents of  ST mixture while VFA mixture as 
                             the carbon source. 
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Figure 4.29 indicates the effect of ES mixture on VFAs concentrations. VFAs were 
started to accumulate after 1 mg/L ES addition. 10 – 25 mg/L concentrations were 
indicated nearly similar trend with each other as in the ST tests. 
 
Figure 4.29 : VFA concentration in effluents of  ES mixture while VFA mixture as 
                             the carbon source. 
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5.  CONCLUSION 
In this study, the short-term effects of TET, ERY, and SMX mixtures, which are 
widely used antibiotics, on methanogenic activity were examined. Acetate, butyrate, 
and VFA mixture were used as the sole carbon sources to evaluate the inhibition 
effect on specific trophic groups of anaerobic process. Antibiotic dosages were in the 
range of 1.0–250 mg/L. Biogas generation/composition and substrate removal were 
monitored during the test period.   
Statistical analyses showed that, there is a strong correlation between antibiotic 
mixture concentration and methane generation. For all substrate conditions, 250 
mg/L ST mixture had the highest inhibitory effect on total methane production. After 
100 mg/L, short-term inhibitory effect of antibiotic mixtures was seen clearly. In the 
acetate fed test bottles, EC50 values of mixtures were calculated lower than single 
compounds. Synergistic effects were observed in the mixtures. Acetoclastic 
methanogens are the most sensitive group of microorganisms participating in the 
anaerobic process. The results showed that, mixtures had higher inhibition effect on 
total methane production of acetoclastic methanogens than single compounds. In 
butyrate set, EC50 values were predicted higher than tested concentrations. Two 
possible explanation can be made for these results. The antagonistic effect might be 
occurred between antibiotics in the mixture or the microorganisms, which 
responsible of butyrate degradation are resistant to the tested antibiotics. In VFA 
mixture fed test bottles, EC50 values were calculated higher than single compounds 
for ETS, ET and ES mixtures surprisingly. The antagonistic effect was seen in these 
test bottles. EC50 value of ST mixture was lower than single SMX, synergistic effect 
was seen in this mixture.  
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